Opendata, web and dolomites
H2020 projects about "therapeutic"
The page lists 1430 projects related to the topic "therapeutic".
| # | |||
|---|---|---|---|
| 1 | ALEC | Aging Lungs in European Cohorts | 2015 |
| 2 | MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients | 2015 |
| 3 | Ageing with elegans | Validating C. elegans healthspan model for better understanding factors causing health and disease, to develop evidence based prevention, diagnostic, therapeutic and other strategies. | 2015 |
| 4 | DYNAHEALTH | Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging | 2015 |
| 5 | DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection | 2015 |
| 6 | ULTRAPLACAD | ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis | 2015 |
| 7 | ENSAT-HT | Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension | 2015 |
| 8 | PoC-ID | Platform for ultra-sensitive Point-of-Care diagnostics for Infectious Diseases | 2015 |
| 9 | EYE-RISK | Exploring the combined role of genetic and non-genetic factors for developing Age-Related Macular Degeneration: A systems level analysis of disease subgroups, risk factors, and pathways | 2015 |
| 10 | REGAIN | REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss | 2015 |
| 11 | nextBioPharmDSP | Next-generation biopharmaceutical downstream process | 2015 |
| 12 | HEARTOFSTROKE | The heart of stroke: Pipes, Perfusion, Parenchyma | 2015 |
| 13 | REPROWORM | Safeguarding Cell Identities: Mechanisms Counteracting Cell Fate Reprogramming | 2015 |
| 14 | PentaBrain | Structural studies of mammalian Cys-loop receptors | 2015 |
| 15 | BREATHE | Biochemically modified messenger RNA encoding nucleases for in vivo gene correction of severe inherited lung diseases | 2015 |
| 16 | ChromArch | Single Molecule Mechanisms of Spatio-Temporal Chromatin Architecture | 2015 |
| 17 | AngioGenesHD | Epistasis analysis of angiogenes with high cellular definition | 2015 |
| 18 | NEUROMITO | Elucidating Neuronal Susceptibility to Mitochondrial Disease | 2015 |
| 19 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 20 | NOVA | Non-coding RNA in Vascular Ageing | 2015 |
| 21 | ROBOTAR | Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents | 2015 |
| 22 | SILENCE | Mechanisms of Gene Silencing by the Glucocorticoid Receptor | 2015 |
| 23 | aLzINK | Alzheimer's disease and Zinc: the missing link ? | 2015 |
| 24 | DE-ORPHAN | DEtermination of Orphan Receptor PHysiological Agonists and sigNals | 2015 |
| 25 | ComBact | How complement molecules kill bacteria | 2015 |
| 26 | FLDcure | A potent Micro-RNA therapeutic for nonalcoholic fatty liver disease (NAFLD) | 2015 |
| 27 | aCROBAT | Circadian Regulation Of Brown Adipose Thermogenesis | 2015 |
| 28 | REMEMBER | Adaptive immunity in prokaryotes: how Bacteria do not forgive and do not forget their enemies | 2015 |
| 29 | CorticALS | Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies | 2015 |
| 30 | SOS | Sorting of Self | 2015 |
| 31 | VEGFDANI | Novel enhancers of functional recovery after stroke | 2015 |
| 32 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 33 | CannaPreg | Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes | 2015 |
| 34 | TheLiRep | Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes | 2015 |
| 35 | BALaNCE | BreAking the Link betweeN myo10 and CancEr | 2015 |
| 36 | CCMI-ARDS | Medically Licensed Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome. | 2015 |
| 37 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
| 38 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 39 | NABBA | Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases | 2015 |
| 40 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 41 | RADIATE | Radiation Innovations for Therapy and Education | 2015 |
| 42 | BIOGEL | Engineering responsive and biomimetic hydrogels for biomedical therapeutic and diagnostic applications | 2015 |
| 43 | BonePain | European Training Network on Bone Pain | 2015 |
| 44 | HyMedPoly | Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications | 2015 |
| 45 | Biorapid | Rapid Bioprocess Development | 2015 |
| 46 | m-RESIST | Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia | 2015 |
| 47 | RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease. | 2015 |
| 48 | ARISE | Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap | 2015 |
| 49 | TREGeneration | Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes | 2015 |
| 50 | openMedicine | openMedicine | 2015 |
| 51 | ADIPOA2 | Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis | 2015 |
| 52 | eNHANCE | eNHANCE - intention based enhancement of reaching and grasping in physically disabled people - personalized to maximize user performance | 2015 |
| 53 | MEDILIGHT | Miniaturized smart system for light stimulation and monitoring of wound healing | 2015 |
| 54 | PRISAR | Preclinical Intra-Operative Image-Guided Surgery and Post-Operative Radiotherapy of Tumours | 2015 |
| 55 | Muscle stress relief | Muscle Stress Relief: An integrated research program linking together basic research on secondary myopathies in stress states to innovative translation in applied myology. | 2016 |
| 56 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 57 | MACIVIVA | MAnufacturing process for Cold-chain Independent VIrosome-based VAccines | 2015 |
| 58 | NANOFACTURING | The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals | 2015 |
| 59 | LYMPHORG | Organ-specific mechanisms of lymphatic vascular development and specialisation | 2015 |
| 60 | SynChI | Striatal cholinergic cell assemblies in movement disorders | 2015 |
| 61 | NICHOID | Mechanobiology of nuclear import of transcription factors modeled within a bioengineered stem cell niche. | 2015 |
| 62 | RINGE3 | Structural and mechanistic insights into RING E3-mediated ubiquitination | 2015 |
| 63 | ASTHMAPOC | Disposable nitric oxide POC (point-of-care) test for home care easy management of asthma in chronic patients | 2014 |
| 64 | BMEVLP | Biomarkers for clinical assessment of lungs intended for transplantation | 2014 |
| 65 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 66 | COMBPDCHEMOTHERAPY | Rational design of combined PDT photosensitizers and chemotherapeutic agent as new approach in cancer therapy: a computational approach | 2015 |
| 67 | MitSyn | Alpha-synuclein and mitochondrial dysfunction: key links between Gaucher’s disease and Parkinson’s? | 2015 |
| 68 | RESCUE THE HEART | Understanding nervous mechanisms of cardioprotection to save the ischaemic and failing hearts | 2016 |
| 69 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 70 | MENTAL IMAGERY | The power of imagination – Breaking through behavioural avoidance in depression with mental imagery | 2016 |
| 71 | CircaDopamine | The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms | 2015 |
| 72 | CONSORT | Controlled Singlet Oxygen Release Photosensitizers in Photodynamic Therapy | 2015 |
| 73 | BBLOCK | Stereocontrolled synthesis of polypropionates based on building block assembly strategies by lithiation-borylation methodologies | 2015 |
| 74 | BioMASCE | Biophysical Manipulation of Adult Stem Cell Epigenetics (BioMASCE) By Cell-Penetrating Nanoneedle Substrates | 2016 |
| 75 | miROMeS | miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients | 2015 |
| 76 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
| 77 | mini-liver SCCS | Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments | 2016 |
| 78 | PoreSelect | Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein | 2016 |
| 79 | IMSTREV | Immune modulation by lymph node stromal cell-derived extracellular vesicles | 2015 |
| 80 | BaCTher | Bacteria for Cancer Therapy | 2015 |
| 81 | GUTWORM | Unravelling host intestine-parasite interactions that define immune responses to whipworms | 2015 |
| 82 | 7DUP | Characterization of 7q11.23 reciprocal aneusomy syndromes: from patients to functional pathways (and back) | 2016 |
| 83 | KSHV QTV | Identification of novel KSHV immune evasion mechanisms using a quantitative temporal viromics analysis | 2015 |
| 84 | ELSWIFLUOPRO | Electrochemically Switchable Fluorescent Probes for Biological Applications | 2015 |
| 85 | ASF_SwineResistance | African Swine Fever, the Sus scrofa evolutionary genomic response | 2015 |
| 86 | TANYFEEDNEURONS | Gliotransmission and shuttling of metabolic signals to feeding neuronal circuits by tanycytes | 2015 |
| 87 | GLIODIABESITY | ROLE OF THE TANYCYTIC BARRIER AT THE BLOOD-HYPOTHALAMUS INTERFACE DURING METABOLIC DISORDER DEVELOPMENT | 2015 |
| 88 | RvD3-RAVIS | Novel Resolvin D3: its Role and Actions in the Resolution of Aortic Valvular Inflammation and Stenosis | 2015 |
| 89 | CHELALZ | Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies | 2016 |
| 90 | EDPAS | Regulation of early embryo development and pluripotency through alternative splicing | 2015 |
| 91 | VCSD | Visualising Chromatin Structure and Dynamics at the Nanometre Scale with Super-Resolution Fluorescence Microscopy | 2016 |
| 92 | REDOxHEART | The Role of Adipose-Tissue Derived wnt-ligands in the Regulation of Myocardial Redox Signalling | 2015 |
| 93 | MRTGS | Mechanical regulation of tissue growth and signalling | 2016 |
| 94 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
| 95 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 96 | RESCBONE | The influence of mechanical loading on the decline in bone mass with ageing | 2015 |
| 97 | SilentFACT | Functional networks and cancer roles of the essential histone chaperone FACT | 2015 |
| 98 | ICSIS | The interaction and clearance of senescent vascular cells by the innate immune system | 2015 |
| 99 | SECOMAP | Sexual Commitment of Malaria Parasites: Investigation Into the Epigenetic Control of Plasmodium Gametocytogenesis | 2015 |
| 100 | RejuvenateBone | Enhancing the regeneration of bone defects in elderly: Rejuvenation of bone microenvironment | 2015 |
| 101 | BURK-6 | Investigation of the Type VI secretion system-associated toxins of Burkholderia thailandensis | 2015 |
| 102 | PEMETH | Planning and Evaluation Methodologies for Mental Healthcare Buildings | 2015 |
| 103 | MitoTAGs | Developing next-generation tools for mitochondrial dissection with cell-specific resolution. | 2015 |
| 104 | PromoTeRapy | Haploinsufficiency and Intractable Epilepsy Rescue Increasing Endogenous Gene PromoterEfficiency | 2016 |
| 105 | MSMART | Margination of Microcapsules in Small Arteries | 2015 |
| 106 | ROR2BONE | Investigating Ror2-dependent non-canonical Wnt signaling in bone remodeling | 2015 |
| 107 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
| 108 | MediVAC | Bio-sustainable production of natural medicines from Vitex | 2015 |
| 109 | GLYCODIS3 | Genetic correction of glycogen debranching enzyme deficiency in Glycogen Storage disease III: a proof of concept study | 2016 |
| 110 | Micropod | MICROPOrous Devices for next-generation therapeutic delivery | 2015 |
| 111 | Magnetic HEART | Targeting the Human Myocardial Remodeling Process Using Novel Magnetic Force-Based Human Heart Tissue | 2016 |
| 112 | RECOLOR | Regulation and consequences of LRRK2 phosphorylation,a path to Parkinson’s disease therapy and diagnostics | 2015 |
| 113 | nAChR PAM-to-gate | Gating mechanism and pharmacological modulation of nicotinic acetylcholine receptors | 2015 |
| 114 | CR-PHAGOCYTOSIS | Complement-mediated phagocytosis in neutrophils | 2015 |
| 115 | CICCI | Characterization of Intestinal Cancer Cell Invasion | 2015 |
| 116 | EVOLPREG | Origination of novel gene regulatory networks in the evolution of mammalian pregnancy | 2016 |
| 117 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
| 118 | REALISM | Reducing Early Atrophy with Leucine during Immobilization of Skeletal Muscle | 2015 |
| 119 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 120 | miRNAs in TH2 cells | Role of extracellular miRNAs in T cell development, TH2 cell differentiation and TH2 cell-mediated effector function | 2015 |
| 121 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 122 | BRIDGES | Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients | 2015 |
| 123 | FUNC NGS | Deep screening of proteins with a next generation sequencing platform | 2015 |
| 124 | depreg | Antidepressants during pregnancy: underlying mechanisms associated with neurodevelopmental outcome | 2015 |
| 125 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 126 | HyHeat | Profiling gene expression in Hydra vulgaris following Gold Nanoparticle-mediated hyperthermia | 2015 |
| 127 | EGFR-Activ | Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights | 2015 |
| 128 | OPTOFRAX | Optopharmacological brain mapping of autism mouse models | 2015 |
| 129 | eADAM | Ultra-small electrochemical aptasensors for specific dopamine real-time monitoring | 2016 |
| 130 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 131 | Beta-splicenet | ALTERNATIVE SPLICING NETWORKS IN PANCREATIC BETA CELLS | 2015 |
| 132 | FISHDOPA | Dopaminergic neurons and the reward system in fish: a functional neuroanatomical multidisciplinary study | 2016 |
| 133 | POSEIDON | novel bioreactor Platform for reprOducible, Scalable ExpansIonand cardiac DifferentiatiON of hiPSC in suspension culture | 2015 |
| 134 | Re.B.Us | Rewiring Brain Units - bridging the gap of neuronal communication by means of intelligent hybrid systems | 2016 |
| 135 | MINERVA | Micro-RNAs of neutrophils in renal ANCA-associated vasculitis | 2016 |
| 136 | Lx Micelles | Coordination chemistry in doubly stabilized micelles for the tageted delivery of cytostatic drugs in cancer therapy | 2015 |
| 137 | SORT1LIG | Identification and characterization of new cytosolic ligands of Sortilin | 2016 |
| 138 | LYMPHOSIGN | Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 |
| 139 | Athero MPh proliferation | Macrophage proliferation and ontogeny in murine models of atherosclerosis | 2016 |
| 140 | TITLY | Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma | 2015 |
| 141 | REBuILD | Exploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseases | 2016 |
| 142 | BRCA2Interact | Structural and biochemical characterization of pre-recombination complexes | 2015 |
| 143 | EPI_nanoSTIM | Enabling motor control after a spinal cord injury through nanoscaled electrical | 2015 |
| 144 | NMJALS | In vivo analysis of neuromuscular junction stability in zebrafish models of amyotrophic lateral sclerosis | 2015 |
| 145 | CARDIOTOX | Predicting Cardiotoxicity Induced by Kinase Inhibitors: From Systems Biology to Systems Pharmacology | 2015 |
| 146 | InCisive | creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease | 2016 |
| 147 | PROMETEO | Reconstructing human oral microbiome composition changes over the last 8000 years with proteomics and metagenomics approaches | 2016 |
| 148 | ADDITION | Arthritis Differential DIagnostic validaTION | 2015 |
| 149 | MalaDiag | Development of a very rapid diagnostic test for malaria, based on break-through detection technology and new biomarkers of infection. | 2014 |
| 150 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 151 | RodBot | Automated Microhandling System for X-ray Crystallography | 2015 |
| 152 | miRaColl | miRNA-activated Scaffold Technologies for Cartilage Regeneration | 2015 |
| 153 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
| 154 | IF-EBOla | Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy | 2014 |
| 155 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
| 156 | HUMICE | AXENIS Humanized Mice – Innovation towards industrial scale-up | 2015 |
| 157 | DEALS | Biomarker assay development to expedite ALS experimental therapeutic advancement | 2015 |
| 158 | Vaprosep | Validation of Progranulin as Biomarker in Diagnostics and Prognosis of Sepsis | 2015 |
| 159 | FGFSTAB | Industrial Production of Stable Fibroblast Growth Factors for Broad Therapeutic, Research, and Personal Care Applications | 2015 |
| 160 | EDePDAC | Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA | 2015 |
| 161 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 162 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 163 | MgSpa | A highly efficient and eco-friendly electric shower offering health benefits through magnesium sulphate | 2015 |
| 164 | REGHA | Medical device combining viscosupplementation with pharmacological active molecule to regenerate cartilage in degenerative or traumatic osteoarthritis. | 2015 |
| 165 | 3Dconvert | The dynamics of the mammalian epigenome during transcription factor-induced cell fate conversion | 2015 |
| 166 | GAMES | Gut Microbiota in Nervous System Autoimmunity: Molecular Mechanisms of Disease Initiation and Regulation | 2015 |
| 167 | ONCOMECHAML | Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia | 2015 |
| 168 | FAtoUnFRAGILITY | Fanconi anemia : a disease model to understand causes and consequences of common fragile site instability. | 2015 |
| 169 | MechanoFate | From mechanical stress to vascular fate | 2016 |
| 170 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 171 | Enhancer ID | Identification and functional characterization of mammalian enhancers and transcriptional co-factors during cellular signaling and cell fate transitions | 2015 |
| 172 | A-DIET | Metabolomics based biomarkers of dietary intake- new tools for nutrition research | 2015 |
| 173 | NeuroInCellNMR | In-cell NMR monitoring of alpha-Synuclein aggregation in neuronal cells | 2015 |
| 174 | LONGHEART | Exploring selected long non-coding RNAs as diagnostics and therapeutic targets for heart failure | 2015 |
| 175 | C9ND | C9orf72-mediated neurodegeneration: mechanisms and therapeutics | 2015 |
| 176 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 177 | DDRNA | DDRNA-based cancer therapy targeted telomeres | 2015 |
| 178 | MRG-GRammar | Massive Reverse Genomics to Decipher Gene Regulatory Grammar | 2015 |
| 179 | CONQUER | Contrast by Quadrupole Enhanced Relaxation | 2015 |
| 180 | IC-3i-PhD | Institut Curie 3-i PhD Program | 2016 |
| 181 | RAIL | Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy | 2015 |
| 182 | DAFAP | Development of Advanced Functional Absorbent Products | 2015 |
| 183 | DERMADROP | DERMADROP - A COMPREHENSIVE TRANSDERMAL THERAPY CONCEPT FOR NON- HEALING WOUNDS AND OTHER SKIN DISORDERS | 2015 |
| 184 | BIOCAPAN | BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy | 2015 |
| 185 | VERTICAL CITY | Versatility of scaffold complexes in vivo to control synaptic plasticity | 2015 |
| 186 | DBSModel | Multiscale Modelling of the Neuromuscular System for Closed Loop Deep Brain Stimulation | 2015 |
| 187 | Calcivis CAIS | Validation of clinical performance and pre-commercial development of a novel diagnostic for dental caries assessment | 2015 |
| 188 | Inflammostrome | Stromal cells as primary drivers of immunopathology: towards targeted disease modification in spondyloarthritis | 2015 |
| 189 | PNANOMED | Personalized Nanomedicines for Leukemia Patients | 2015 |
| 190 | Profile Infection | Unraveling changes in cellular gene expression during viral infection | 2015 |
| 191 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 192 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
| 193 | JointPrinting | 3D Printing of Cell Laden Biomimetic Materials and Biomolecules for Joint Regeneration | 2015 |
| 194 | CONCERT | Description of information transfer across macromolecules by concerted conformational changes | 2015 |
| 195 | ZF-MEL-CHEMBIO | Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma | 2015 |
| 196 | PULTAR | Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics | 2015 |
| 197 | SWORD | Advanced Analytics Platform for Stroke Patients Rehabilitation | 2015 |
| 198 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
| 199 | UltraEASY | Computer Aided Multispectral Ulstrasound Diagnostic Device | 2015 |
| 200 | AnandaCor | Concept and feasibility assessment for AnandaCor, a fast melting tablet, as a diagnostic device in ischemic heart conditions. | 2015 |
| 201 | BIOELECPRO | Frontier Research on the Dielectric Properties of Biological Tissue | 2015 |
| 202 | CARDYADS | Controlling Cardiomyocyte Dyadic Structure | 2015 |
| 203 | CSC-IS | Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 |
| 204 | PROTEOMICAN | Discovery of breast cancer aggressiveness markers using topo-proteomics mapping | 2015 |
| 205 | RENOIR | RENal prOgenItoRs as tools to understand kidney pathophysiology and treat kidney disorders | 2015 |
| 206 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 207 | SmartCardiacPatch | Next-Generation Cardiac Tissue Engineering: Smart Self-Regulating Patches | 2015 |
| 208 | HemNichMDS | Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes. | 2015 |
| 209 | YOUNGatHEART | YOUNGatHEART: CARDIAC REJUVENATION BY EPIGENETIC REMODELLING | 2015 |
| 210 | MaTissE | Magnetic approaches for Tissue Mechanics and Engineering | 2015 |
| 211 | TIPPDECRA | Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis | 2016 |
| 212 | PRIISM-HD | Pathways Regulating Intramyocellular Insulin Sensitivity and Metabolism in Health and Disease | 2016 |
| 213 | STARS | Strategies Targeting Thyroid Hormone in Athrophy Related Syndromes | 2015 |
| 214 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 215 | CaSR Biomedicine | Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases | 2016 |
| 216 | Novel asthma therapy | Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy | 2015 |
| 217 | COMAL | COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics | 2015 |
| 218 | miRNA in Immunity | Testing the role of miRNA-mediated non-cell autonomous gene regulation in type-2 immunity | 2015 |
| 219 | SIRENE | Silencing miR-199b to attenuate the progression of heart failure. | 2015 |
| 220 | DNA2REPAIR | DNA strand break repair and links to human disease | 2015 |
| 221 | AUROMYC | N-Myc and Aurora A: From Protein Stability to Chromosome TopologyN-Myc and Aurora A: From Protein Stability to Chromosome TopologyMyc and Aurora A: From Protein Stability to Chromosome Topology | 2015 |
| 222 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 223 | PIPPI | Protein-excipient Interactions and Protein-Protein Interactions in formulation | 2016 |
| 224 | EVOluTION | European Vascular Interventions and Therapeutic Innovation Network | 2016 |
| 225 | TASPPI | Targeted small-molecule Stabilisation of Protein-Protein Interactions | 2016 |
| 226 | Phd | Deciphering PI3K biology in health and disease | 2015 |
| 227 | ENLIGHT-TEN | European Network linking informatics and genomics of helper T cells | 2015 |
| 228 | BtRAIN | Brain barriers training | 2015 |
| 229 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 230 | BrainMatTrain | Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach | 2016 |
| 231 | GlyCoCan | Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics | 2015 |
| 232 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 233 | LeukoTheranostics | Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease | 2015 |
| 234 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 235 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 236 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 237 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
| 238 | ISOTOPICS | ISOTOPIC LABELING FOR DRUG INNOVATION | 2016 |
| 239 | TRAIN-ERS | Endoplasmic Reticulum Stress in Health and Disease | 2015 |
| 240 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 241 | REGMAMKID | How to regenerate the mammalian kidney | 2015 |
| 242 | TOPOmics | Global dynamics of topoisomerase-induced DNA breaks | 2015 |
| 243 | iPROTECTION | Molecular mechanisms of induced protection against sepsis by DNA damage responses | 2015 |
| 244 | MYOP-PATH | Towards solving myopia: from genes to pathways using an integrated approach | 2015 |
| 245 | resistance evolution | Bacterial evolution of hypersensitivity and resistance against antimicrobial peptides | 2015 |
| 246 | EVAg | European Virus Archive goes global | 2015 |
| 247 | MYCOCHASSIS | Engineering of a minimal bacterial therapeutic chassis | 2015 |
| 248 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 249 | 5HTCircuits | Modulation of cortical circuits and predictive neural coding by serotonin | 2016 |
| 250 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
| 251 | NEURON Cofund | ERA NET NEURON in the area of brain-related diseases and disorders of the nervous system | 2016 |
| 252 | TETRA | Autologous Stem Cell Seeded Tissue Engineered Trachea | 2016 |
| 253 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
| 254 | RESSTORE | REgenerative Stem cell therapy for STroke in Europe | 2015 |
| 255 | BetaCellTherapy | Beta Cell Generation by Stem Cell-Derived Implants in Diabetes | 2015 |
| 256 | BIO-CHIP | BIOengineered grafts for Cartilage Healing In Patients (BIO-CHIP) | 2015 |
| 257 | EAVI2020 | European AIDS Vaccine Initiative 2020 | 2015 |
| 258 | MOZART | MesopOrous matrices for localiZed pH-triggered releAse of theRapeuTic ions and drugs | 2015 |
| 259 | Ocean Medicines | Ocean Medicines | 2015 |
| 260 | ERROR | A pEdiatRic dosimetRy personalized platfORm based on computational anthropomorphic phantoms | 2016 |
| 261 | PLANTIBIOTICS | Functional ingredient from fermented vegetable waste streams to diminish the use of antibiotics in pig husbandry | 2015 |
| 262 | MARA | Molecular Analytical Robotics Assays | 2015 |
| 263 | JUMPAIR | JUMPAIR: Decubitus Ulcers Diseases Diagnoses by means of Smart Anti-Decubitus System based on known Ulcers Activity Biomarkers | 2015 |
| 264 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 265 | LeukoPredict | LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). | 2016 |
| 266 | iMPACT | innovative Medical Protons Achromatic Calorimeter and Tracker | 2016 |
| 267 | DYNAP | Dynamic Penetrating Peptide Adaptamers | 2016 |
| 268 | REGENETHER | Modeling and treating retinal degenerative disease | 2015 |
| 269 | HIV1ABTHERAPY | Antibody-Mediated Therapy of HIV-1 Infection | 2016 |
| 270 | rEnDOx | REDOX SIGNALING AND METABOLIC STATES IN ANGIOGENESIS IN HEALTH AND DISEASE | 2016 |
| 271 | EDeN | Ependymal cell Development: New insight into neurological diseases | 2015 |
| 272 | CODOVIREVOL | Evolution of viral codon usage preferences:manipulation of translation accuracy and evasion of immune response | 2016 |
| 273 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 274 | MemoMCI | Targeting reconsolidation to strengthen memories in individuals with Mild Cognitive Impairment | 2016 |
| 275 | SVDs-at-target | Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia | 2016 |
| 276 | BATCure | Developing new therapies for Batten disease | 2016 |
| 277 | VISION DMD | VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy | 2016 |
| 278 | TAT-CF | Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters | 2016 |
| 279 | Angiolnc | Endothelial long non-coding RNAs | 2016 |
| 280 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 281 | HemAcure | Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A | 2015 |
| 282 | MYOCURE | Development of an innovative gene therapy platform to cure rare hereditary muscle disorders | 2016 |
| 283 | UM Cure 2020 | New therapies for uveal melanoma | 2016 |
| 284 | REPROGRAM | Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 |
| 285 | AUTOSTEM | Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient” | 2016 |
| 286 | PIBD-SETQuality | Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care | 2016 |
| 287 | FORCE | Imaging the Force of Cancer | 2016 |
| 288 | LSFM4LIFE | Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of type 1 diabetes | 2016 |
| 289 | TECHNOBEAT | Tools and TECHNOlogies for Breakthrough in hEArt Therapies | 2016 |
| 290 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
| 291 | SyBil-AA | Systems Biology of Alcohol Addiction: Modeling and validating disease state networks in human and animal brains for understanding pathophysiolgy, predicting outcomes and improving therapy | 2016 |
| 292 | AsthmaPhenotypes | Understanding asthma phenotypes: going beyond the atopic/non-atopic paradigm | 2016 |
| 293 | EvoGenMed | Evolutionary genomics: new perspectives and novel medical applications | 2016 |
| 294 | StemBAT | New players in human BAT differentiation and activation: a human PSC-derived BAT approach combined with state of the art genome engineering and –omics based methodologies | 2016 |
| 295 | CleverGenes | Novel Gene Therapy Based on the Activation of Endogenous Genes for the Treatment of Ischemia - Concepts of endogenetherapy, release of promoter pausing, promoter-targeted ncRNAs and nuclear RNAi | 2015 |
| 296 | MyeliNANO | Myelinic nanochannels in neurodegenerative diseases | 2016 |
| 297 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 298 | Endoo | Endoscopic versatile robotic guidance, diagnosis and therapy of magnetic-driven soft-tethered endoluminal robots | 2015 |
| 299 | Digi-NewB | Non-invasive monitoring of perinatal health through multiparametric digital representation of clinically relevant functions for improving clinical intervention in neonatal units (Digi-NewB) | 2016 |
| 300 | assymcurv | The influence of the cell membrane asymmetry and curvature on the functioning of membrane proteins and the transport of therapeutic compounds | 2016 |
| 301 | NANO-SUPREMI | “Tracking nano-bioprocesses using Super-Resolution Microscopy Techniques” | 2016 |
| 302 | EPIC | Exploiting Protein Complexes that Induce Cell-death | 2016 |
| 303 | PELICO | Peptidomimetics with photocontrolled biological activity | 2016 |
| 304 | EXANDAS | Exploitation of aromatic plants’ by-products for the development of novel cosmeceuticals and food supplements. | 2016 |
| 305 | IMPEDE | Immunomodulatory effects of sustained pantethine release in inflammatory diseases | 2016 |
| 306 | ARREST BLINDNESS | Advanced Regenerative and REStorative Therapies to combat corneal BLINDNESS | 2016 |
| 307 | RELIEF | RECOVERING LIFE WELLBEING THROUGH PAIN SELF-MANAGEMENT TECHNIQUES INVOLVING ICTs | 2016 |
| 308 | PrECISE | PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION | 2016 |
| 309 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 310 | EPITOOLS | Chemical biology approaches to unraveling the histone code | 2016 |
| 311 | ASTROCIT | Development and validation of an innovative nutritional solution to fight muscle atrophy during human space flights, application of the acquired knowledge to prevent muscle degeneration down on earth | 2016 |
| 312 | MIROR | Methods in Research on Research | 2016 |
| 313 | GvHDCure | Understanding the dynamics of the immune system to cure graft-versus-host disease (GvHD). | 2016 |
| 314 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
| 315 | microCardio | Functional high-throughput analysis of the role of microRNAs in cardiac ischemia-reperfusion injury | 2016 |
| 316 | SENSE-Cog | Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment | 2016 |
| 317 | ICARO | Colloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | 2016 |
| 318 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 319 | PAPAstudy | Podocyte Adaptation Proliferation and Ageing | 2016 |
| 320 | RITA-MI | Rituximab in Acute Myocardial Infarction | 2016 |
| 321 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 322 | PRIMASE_NMR | Visualizing Primase Initiating DNA Replication using NMR Spectroscopy | 2016 |
| 323 | ThruBlood | Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer | 2016 |
| 324 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 325 | BioMNP | Understanding the interaction between metal nanoparticles and biological membranes | 2016 |
| 326 | MCTRinIA | Resolution Pharmacology and Physiology of MCTR in Arthritis | 2016 |
| 327 | INTEGHER | Integration of herpesvirus into telomeres: From the mechanism of genome integration and mobilization to therapeutic intervention | 2016 |
| 328 | RespMicroFlows | Unravelling respiratory microflows in silico and in vitro: novel paths for targeted pulmonary delivery in infants and young children | 2016 |
| 329 | PEP-PRO-RNA | Peptide-derived bioavailable macrocycles as inhibitors of protein-RNA and protein-protein interactions | 2016 |
| 330 | HOLDING-HANDS | Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy | 2016 |
| 331 | inHForm | Integrative omics of heart failure to inform discovery of novel drug targets and clinical biomarkers | 2016 |
| 332 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 333 | PolyDomFormFuncReg | Discovering how polycomb domains form and function in gene regulation | 2016 |
| 334 | PSYCHOCELL | Cellular substrate of abnormal network maturation in neuropsychiatric disorders | 2016 |
| 335 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 336 | PANA | PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES. | 2016 |
| 337 | MOMENDO | Molecular Mechanisms of Endometriosis | 2016 |
| 338 | hRBP-virion | Comprehensive identification of host factors involved in the early steps of HIV infection. | 2017 |
| 339 | OptoNMDA | Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential | 2016 |
| 340 | NEUROTUNN | Mechanisms of α-synuclein spreading, implications for synucleinopathies | 2016 |
| 341 | G4-PTROs | Regulatory network of G-quadruplex dependent Post-Transcriptional mRNA Operons (PTROs) | 2016 |
| 342 | MTUB-ANGIO | Microtubule Dynamics during angiogenesis | 2016 |
| 343 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 344 | PrecTherLSCC | Precision Therapies in Lung Squamous Cell Carcinoma | 2016 |
| 345 | MCNANO | “Multi-component nanoparticles as bimodal contrast agents for MRI and optical detection of tumors and for targeted photodynamic therapy” | 2016 |
| 346 | SmartCubes | An innovative class of nanoparticles (“SmartCubes”) for the targeted delivery of protein therapeutics | 2016 |
| 347 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 348 | MCANALSMSCA2015 | Receptor signalling in space and time - Gaining high-resolution information of the temporal and spatial control of G protein-coupled receptor signalling. | 2018 |
| 349 | PURKINJEREG | Identification of cellular identities and characterization of the STAT3 signalling pathway in Purkinje cell layer regeneration | 2016 |
| 350 | RETICULUS | Integration of retinal inputs by distinct collicular cell types | 2017 |
| 351 | MIRNANO | Multifunctional miRNA-targeting nanodevices for pluripotent cancer theranostics | 2017 |
| 352 | MPSC | Membrane Potential and Stem Cell Potency in Normal and Malignant Tissues | 2016 |
| 353 | NuSiCC | Modelling the therapeutic potential of NUAK1 suppression in colorectal cancer | 2016 |
| 354 | Multi-SIP Hydrogel | A multifunctional self-immolative hydrogel for accelerating the healing of chronic wounds | 2017 |
| 355 | Cleanup-MOFs | Decontamination of emerging pollutant using porous Metal-Organic Frameworks (MOFs) and silica-MOFs composites | 2016 |
| 356 | MONOCLE | A novel enhancer deletion strategy to determine non-classical monocyte function in atherosclerosis | 2017 |
| 357 | Cells-in-drops | High throughput screening of single-cells using droplet microfluidics | 2016 |
| 358 | KILLINGTYPHI | Identification of host-factors restricting Salmonella Typhi | 2016 |
| 359 | Prionomics | Systematic profiling of molecular changes during prion disease progression | 2016 |
| 360 | GCG-T3 Dyslipidemia | Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease | 2016 |
| 361 | GRNHairCell | Understanding the Gene Regulatory Network involved inner ear Hair Cell differentiation | 2016 |
| 362 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
| 363 | MiroMigration | Miro dependent mitochondrial dynamics and the regulation of neuronal migration | 2016 |
| 364 | EpiMIRgen | A comprehensive analysis of microRNA-124 regulated gene networks and its role in epilepsy. | 2016 |
| 365 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 366 | CIRCLE | Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia | 2016 |
| 367 | HeartAtaK | Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel | 2016 |
| 368 | ADHDLightUp | Circuit-based deconstruction of Attention deficit and Hyperactive disorder with optogenetic Light control | 2016 |
| 369 | NVHSC | Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias | 2016 |
| 370 | CAMEOS | Cardiac micro-engineered tissue for high-throughput screening | 2016 |
| 371 | OPTBIOMAN | Optimal Decision Making under Uncertainty in Biomanufacturing Operations | 2016 |
| 372 | MS Fatigue_Therapy | Objectively Measuring MS Fatigue | 2016 |
| 373 | EC GNG metabolism | Endothelial Gluconeogenesis: a novel target for tumor anti-angiogenesis? | 2017 |
| 374 | FCSSSLP | First Chemoselective Synthesis and Structural Studies of Lasso Peptides | 2016 |
| 375 | MIR-CHROM-C | Investigating the microRNA-chromatin remodelling circuitry in cardiac development | 2016 |
| 376 | BiCyHePepDi | Bicyclic hetero peptidimer - a novel molecule format for therapeutic peptides | 2016 |
| 377 | NORVAS | Therapeutic and Biomarker Potential of long non-coding RNAs in Vascular Disease | 2016 |
| 378 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 379 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 380 | IdrSeq | Discovery and characterization of functional disordered regions and the genes involved in their regulation through next generation sequencing | 2016 |
| 381 | SUPRABIOTICS | Supramolecular Protective Groups Enabling Antibiotics and Bioimaging | 2016 |
| 382 | DeBoRA | Dopamine and Bone Metabolism in Rheumatoid Arthritis | 2016 |
| 383 | Wnt and CRC | Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors | 2017 |
| 384 | InnateMSDyn | Combining in vivo spectral biphoton imaging and multiparametric cytometry to characterize the dynamics of the innate immune response in a multiple sclerosis mouse model | 2016 |
| 385 | NANOBreg | A new therapeutic platform based on nanotechnology to promote T- and B-regulatory networks | 2016 |
| 386 | EpiHope | Epigenetic biomarkers for prediction of vascular complications and response to treatment in subjects with diabetes | 2016 |
| 387 | WntELECT | Wnt Enhancer LandscapE CharacTerization | 2016 |
| 388 | DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma | 2017 |
| 389 | IcoCell | Cell line development platform for SMEs to reduce the length and cost of biologic drug development | 2016 |
| 390 | PET3D | PET Imaging in Drug Design and Development | 2016 |
| 391 | Immune Regulation | How Infection History Shapes the Immune System: Pathogen-induced Changes in Regulatory T Cells | 2016 |
| 392 | SCoTMOF | Combined Chemo- and Radiotherapies by Controlling the Surface Chemistry of Truncated Metal Organic Framework Nanoparticles | 2016 |
| 393 | KILLCANCER | Nanobody-targeted photodynamic therapy to kill cancer | 2016 |
| 394 | DynaOmics | From longitudinal proteomics to dynamic individualized diagnostics | 2016 |
| 395 | Niche Fibrosis | Identification of regulatory signals from vascular niche in alveolar regeneration and pulmonary fibrosis | 2016 |
| 396 | METAFLUIDICS | Advanced toolbox for rapid and cost-effective functional metagenomic screening - microbiology meets microfluidics. | 2016 |
| 397 | AD-gut | Alzheimer Disease - gut connection | 2016 |
| 398 | GUIDESIGINT | Competitive assembly dynamics of the DCC receptor with its guidance cues integrates signals for cellular steering | 2017 |
| 399 | InjectCHA | Local delivery of PTH(1-34) from an injectable collagen-hydroxyapatite scaffold for non-invasive treatment of bisphosphonate associated atypical femoral fractures | 2016 |
| 400 | Schizophrenia Organoids | Understanding the role of parvalbumin interneuron development in schizophrenia using human cerebral organoids | 2017 |
| 401 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 402 | ICLUb | Regulation of DNA interstrand crosslink repair by ubiquitin. | 2016 |
| 403 | BoneImplant | Monitoring bone healing around endosseous implants: from multiscale modeling to the patient’s bed | 2016 |
| 404 | SMILED | Skeletal Muscle Inflammation: ambivalent roles in Exercise and Diabetes | 2016 |
| 405 | Toxoplasma sensing | Cytoplasmic sensing of Toxoplasma gondii infection and host cell programmed necrosis | 2016 |
| 406 | PANDORA | Platelets: at the nexus of brain aneurysm | 2016 |
| 407 | MERC | Molecular mechanisms regulating cardiovascular remodeling by Adamts1 | 2016 |
| 408 | PARAGEN | Biomaterials with incorporated MSC-secreted PARAcrine molecules for bone reGENeration | 2017 |
| 409 | EpiTarget | Epigenome-targeted therapy for cholangiocarcinoma. | 2017 |
| 410 | DMD2CURE | Correction of duplications in the DMD gene by a CRISPR/Cas9 approach | 2017 |
| 411 | EPOC | Understanding the molecular basis of stochastic bi-stable obesity | 2016 |
| 412 | NEURAM | Visual genetics: establishment of a new discipline to visualize neuronal nuclear functions in real-time in intact nervous system by 4D Raman spectroscopy | 2016 |
| 413 | TiDrugArchitectures | Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures | 2016 |
| 414 | VIREX | Mumps VIRus EXploitation of the human adhesion receptor GPR125 | 2016 |
| 415 | DEMETINL | Decisions in metabolic inflammation of the liver: Adhesive interactions involved in leukocyte retention and resolution of inflammation in metabolic-inflammatory liver disease | 2017 |
| 416 | SPLICE3D | CryoEM studies of the spliceosome | 2016 |
| 417 | Nyxoah | Ultra-small implanted neurostimulation device for the treatment of Obstructive Sleep Apnea | 2016 |
| 418 | AGLARIS | AGLARIS: The First Fully-automated Bioreactor for Large Scale Human Stem Cell Production through an Iterative Process. | 2016 |
| 419 | REPLICONSTRAINTS | Dissecting the constraints that define the eukaryotic DNA replication program | 2016 |
| 420 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
| 421 | PyroPop | Mechanisms and regulation of inflammasome-associated programmed cell death | 2017 |
| 422 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 423 | Microbes4U | Study of the therapeutic potential of an Akkermansia muciniphila-based products in subjects with an increased cardio-metabolic risk. | 2016 |
| 424 | CoBABATI | Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations | 2016 |
| 425 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 426 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 427 | BCM-UPS | Dissecting the role of the ubiquitin proteasome system in the pathogenesis and therapy of B-cell malignancies | 2016 |
| 428 | PLEIO-RANK | Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity | 2016 |
| 429 | RAMBO | Mitochondrial DNA degradation and sterile inflammation in the heart | 2016 |
| 430 | TRAIN-HEAL-TH | Empowering expectations for health and disease: Development of a pioneering training tool | 2016 |
| 431 | CDK6-DrugOpp | CDK6 in transcription - turning a foe in a friend | 2016 |
| 432 | CrUCCial | Novel diagnostic and therapeutic approach to inflammatory bowel disease based on functional characterization of patients: the CrUCCial index | 2016 |
| 433 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 434 | Autonomous CLL-BCRs | Role of autonomous B cell receptor signalling and external antigen in the pathogenesis of chronic lymphocytic leukaemia (CLL) | 2016 |
| 435 | SIDSCA | Defective DNA Damage Responses in Dominant Neurodegenerative Diseases | 2016 |
| 436 | RespeCT | Respiratory Disease Screening with Dark-Field Computed Tomography | 2016 |
| 437 | TAROX | Targeting oxidative repair proteins for treatment of cancer and inflammation | 2016 |
| 438 | IMMUNOALZHEIMER | The role of immune cells in Alzheimer's disease | 2016 |
| 439 | iPSCAtaxia | An induced pluripotent stem cell-based neuronal model of Spinocerebellar ataxia | 2016 |
| 440 | AutoStopS | GluCl as an epileptic seizure autoregulatory Gene therapeutic approach | 2016 |
| 441 | LYSOTRACK | Defining the role of lysosomal trafficking in age-associated anabolic resistance in human skeletal muscle | 2016 |
| 442 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 |
| 443 | AngioResist | Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist | 2016 |
| 444 | LSDiASD | Leveraging Small Demethylase inhibitors for Autism Spectrum Disorder | 2016 |
| 445 | AD-VIP | Alzheimer’s disease and AAV9: Use of a virus-based delivery system for vectored immunoprophylaxis in dementia. | 2016 |
| 446 | PFKFBLOCK | Translating fundamental insights in endothelial metabolism: PFKFB3 drug discovery and development | 2016 |
| 447 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 448 | Neuro Care System | Adaptive Neuro Care System | 2016 |
| 449 | FAST-BM | FAST-BM: FibroSelect: delivering A Step-change in Biotherapeutic Manufacturing | 2016 |
| 450 | CardAPcells | Cell therapy for patients with chronic heart failure with proprietary cardiac-derived cells (CardAP cells) – “From the Heart to the Heart” | 2016 |
| 451 | Hybrid S-TORQ | NORDIC DRIVING - SOLUTION FOR TRANSPORT | 2016 |
| 452 | Quality2Cells | TimeLapseReader for Quality Control of Immune Cells used for Cell-Based Therapies | 2016 |
| 453 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 454 | ISOBAR | Cost Effective Personalised Compression Therapy for Chronic Venous Insufficiency with Accurate Pressure Delivery for Comfort and Efficacy of Treatment | 2016 |
| 455 | SHIM | Shim-Scaling mental well-being through an automated self-help app | 2016 |
| 456 | NanoSil4Cancer | Smart Multifunctional silica-based Nanoparticles for Targeted Therapy | 2016 |
| 457 | FAT NKT | Targeting iNKT cell and adipocyte crosstalk for control of metabolism and body weight | 2016 |
| 458 | MYELOMANEXT | Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma | 2016 |
| 459 | Sphingolead | Development of a potent dual GCS/GBA2 inhibitor as a best in class Gaucher therapeutic | 2016 |
| 460 | HypoFlam | Targeting hypothalamic inflammation in obesity and diabetes | 2016 |
| 461 | CERAMENT-BC | A novel bone implant with enhanced bone healing capacity | 2016 |
| 462 | REDOXDRUGS | Discovery and commercialisation of novel compounds targeting redox proteins | 2016 |
| 463 | AstroWireSyn | Wiring synaptic circuits with astroglial connexins: mechanisms, dynamics and impact for critical period plasticity | 2016 |
| 464 | VERDI | polyValent mEsopoRous nanosystem for bone DIseases | 2016 |
| 465 | LYSOSOMICS | Functional Genomics of the Lysosome | 2016 |
| 466 | EYEGET | Gene therapy of inherited retinal diseases | 2017 |
| 467 | HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9. | 2016 |
| 468 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
| 469 | OOCSOCS | Socs3 gene in oocyte maturation and fertilisation - a novel link between inflammation and infertility | 2017 |
| 470 | TRANSMIT | TRANSlating the role of Mitochondria in Tumorigenesis | 2017 |
| 471 | SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network | 2016 |
| 472 | Training4CRM | European Training Network for Cell-based Regenerative Medicine | 2016 |
| 473 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
| 474 | TransPot | Translational Research Network in Prostate Cancer | 2017 |
| 475 | CarBon | Controlling Cartilage to Bone Transitions for Improved Treatment of Bone Defects and Osteoarthritis | 2017 |
| 476 | circRTrain | circular RNA Biology Training Network: from biogenesis to biomarkers | 2017 |
| 477 | REMIX | Regulation of mitochondrial expression | 2016 |
| 478 | Neurogenesis | Exploration and promotion of neurogenesis in the adult brain | 2016 |
| 479 | EMODI | Epithelial resistance modulation to treat disease | 2016 |
| 480 | chemos | Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials | 2016 |
| 481 | CIRDinnova | Shifting the limits of resuscitation with “CIRD Controlled Integrated Resuscitation Device” | 2016 |
| 482 | EPITOR | NEUROBIOLOGY OF EPILEPSY GENES | 2016 |
| 483 | SIRCAH | Secretariat for the International Research Consortium on Animal Health | 2016 |
| 484 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 485 | ChromatinRemodelling | Single-Molecule And Structural Studies Of ATP-Dependent Chromatin Remodelling | 2017 |
| 486 | BIOCDx | A miniature Bio-photonics Companion Diagnostics platform for reliable cancer diagnosis and treatment monitoring. | 2017 |
| 487 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 488 | PATHAD | Pathways to Alzheimer's disease | 2016 |
| 489 | EndoSubvert | Common mechanisms of host membrane trafficking subversion by intracellular pathogens to rupture bacterial containing vacuoles | 2017 |
| 490 | RADoTE | Remote-Activated Delivery of Therapeutic Exosomes (RADoTE) via an Injectable PEG Hydrogel Carrier | 2016 |
| 491 | EXNADMINA | EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease | 2016 |
| 492 | REUSE4MALARIA | Drug Repurposing for Malaria Chemoprotection | 2016 |
| 493 | CYBERLEGs Plus Plus | The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis Plus Plus | 2017 |
| 494 | LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function | 2017 |
| 495 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 496 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 497 | Diet-namic | From fast food to healthy diet: Addressing the dynamic molecular mechanism of sequential diet switch-induced T cell plasticity for the purpose of developing new treatments for immuno-mediated diseases | 2016 |
| 498 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 499 | MIMESIS | A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses | 2016 |
| 500 | NEW DEAL | New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases | 2017 |
| 501 | B-SMART | Brain-Specific, Modular and Active RNA Therapeutics | 2017 |
| 502 | CD40-INN | CD40 goes innate: defining and targeting CD40 signaling intermediates in the macrophage to treat atherosclerosis | 2016 |
| 503 | DiVineGenoMe | Decoding cell-to-cell variation in genome integrity maintenance | 2017 |
| 504 | CUPIDO | Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts | 2017 |
| 505 | OpenRiskNet | OpenRiskNet: Open e-Infrastructure to Support Data Sharing, Knowledge Integration and in silico Analysis and Modelling in Risk Assessment | 2016 |
| 506 | CoBeN | Novel Network-Based Approaches for Studying Cognitive Dysfunction in Behavioral Neurology | 2017 |
| 507 | SkinXCare | Integral cell-biology platform for the development of the first effective treatment of radiodermatitis. | 2016 |
| 508 | pCPR | Personalized cardiopulmonary resuscitation device for emergency teams | 2016 |
| 509 | NONCODRIVERS | Finding noncoding cancer drivers | 2016 |
| 510 | ALS-Networks | Defining functional networks of genetic causes for ALS and related neurodegenerative disorders | 2017 |
| 511 | EVALVE | Biomechanics and signaling in models of congenital heart valve defects | 2016 |
| 512 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 513 | INHIBITHUMAN | Dis-inhibitory circuits in the human cerebral cortex | 2016 |
| 514 | Neuroheart | Cardiovascular Molecular Imaging for Personalized Tailored Treatment | 2017 |
| 515 | CARER-AID | Controlled Autonomous Robot for Early detection and Rehabilitation of Autism and Intellectual Disability | 2017 |
| 516 | AlzDiabetes | Insulin resistance and Tauopathy : Insights from Drosophila models and human brain samples | 2016 |
| 517 | GUTPEPTIDES | Novel therapeutic approaches to improve gastrointestinal wound healing | 2017 |
| 518 | CAVEHEART | Heart regeneration in the Mexican cavefish: The difference between healing and scarring | 2017 |
| 519 | MusEC | UNDERSTANDING THE METABOLIC CROSSTALK BETWEEN THE MUSCLE AND THE ENDOTHELIUM: IMPLICATIONS FOR EXERCISE TRAINING AND INSULIN RESISTANCE | 2017 |
| 520 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 521 | TKI resistance | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors | 2016 |
| 522 | INTRICARE | International Network for Training on Risks of vascular Intimal Calcification And roads to Regression of cardiovascular diseasE | 2017 |
| 523 | MECHANO-CONTROL | Mechanical control of biological function | 2017 |
| 524 | mtFOIE GRAS | mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease | 2017 |
| 525 | Oncosmart | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2016 |
| 526 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 527 | HEXKIN | Healing Exosomes for sKIN | 2016 |
| 528 | MUSIC | Multisystem Cell Therapy for Improvement of Urinary Continence | 2017 |
| 529 | ReGenHeart | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study | 2017 |
| 530 | KidsAP | The artificial pancreas in children aged 1 to 7 years with type 1 diabetes | 2017 |
| 531 | LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | 2017 |
| 532 | PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | 2017 |
| 533 | Lifebrain | Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts | 2017 |
| 534 | SYSCID | A Systems medicine approach to chronic inflammatory disease | 2017 |
| 535 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 536 | MUSCLEGUY | A novel muscle disorders 3D in vitro system for drug screening and validation. | 2016 |
| 537 | miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy | 2016 |
| 538 | DAMOC | Diabetes Approach by Multi-Organ-on-a-Chip | 2017 |
| 539 | BONEPHAGY | Defining the role of the FGF – autophagy axis in bone physiology | 2017 |
| 540 | ChemEpigen | The chemical understanding of biomolecular recognition in epigenetics | 2017 |
| 541 | MODulATE | Gut microbiota-dependent tryptophan metabolism: role in disease pathogenesis and therapeutic target | 2017 |
| 542 | INFRAFRONTIER2020 | Towards enduring mouse resources and services advancing research into human health and disease | 2017 |
| 543 | HIVACAR | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection | 2017 |
| 544 | PAPA-ARTIS | Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial | 2017 |
| 545 | PROOF | Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial | 2017 |
| 546 | CHARMED | Characterisation Of A Green Microenvironment And To Study Its Impact Upon Health and Well-Being in The Elderly As A Way Forward For Health Tourism. | 2017 |
| 547 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 548 | iNAPS | Illuminating Neuronal-Astrocytic Pathways for Sleep homeostasis | 2017 |
| 549 | Bio-ICD | Biological auto-detection and termination of heart rhythm disturbances | 2017 |
| 550 | Keep Control | Industrial Academic Initial Training Network towards specific diagnosis and treatment of age-related gait and balance deficits | 2017 |
| 551 | chromo-SUMMIT | Decoding dynamic chromatin signaling by single-molecule multiplex detection | 2017 |
| 552 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 553 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 554 | NinZA | Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance | 2017 |
| 555 | GLYCONEOBRAIN | Exploring glycosidic neo-epitopes of degenerative hippocampal granules in aged mice and humans: implications for ageing and dementia | 2017 |
| 556 | MIX-Effectors | T6SS MIX-effectors: secretion, activities and use as antibacterial treatment | 2017 |
| 557 | IMMUNE CELL SWARMS | Innate Immune Cell Swarms: Integrating and Adapting Single Cell and Population Dynamics in Inflamed and Infected Tissues | 2017 |
| 558 | TREATCilia | Novel Therapeutic Avenues for dynein-related Ciliopathies | 2017 |
| 559 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 560 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
| 561 | NeuronAgeScreen | A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders | 2017 |
| 562 | NANO-GROWTH | An innovative, non-invasive and de-risked system to enable the transdermal delivery of fragile therapeutic compounds for a better management of painful diseases | 2017 |
| 563 | iTRUST | iTRUST: In-time TReatment of acUte ischaemic STroke | 2017 |
| 564 | DePharm | A cost-effective and energy-efficient water treatment technology to remove pharmaceutical pollutants from urban wastewater | 2016 |
| 565 | COLGENES | Defining novel mechanisms critical for colorectal tumourigenesis | 2017 |
| 566 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 567 | LentiFactory | MAGIC (MAnufacturing of Gene delivery tools for Industrial and Clinical applications) | 2017 |
| 568 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 569 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
| 570 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 571 | TEDCIP | Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras). | 2017 |
| 572 | BRECASTEM | Functional and Molecular Characterisation of Breast Cancer Stem Cells | 2017 |
| 573 | TSH | The Spirited Horse: Human-equid relations in the Bronze Age Near East | 2017 |
| 574 | TRPLigDrugConj | TRPV1-targeted ligand-drug conjugates to treat prostate cancer | 2017 |
| 575 | BRAVEST | Boosting Reward-based Attention through VEstibular STimulation | 2018 |
| 576 | MaRiA | Microbiota and Resolvins in Arthritis | 2017 |
| 577 | eWAD | Unbalanced Wnt signalling in AD: a DNA methylation effect | 2017 |
| 578 | InsiliCardio | Image-based High-resolution In-silico Modeling of Total Cardiac Function | 2017 |
| 579 | EndoMitTalk | Endolysosomal-mitochondria crosstalk in cell and organism homeostasis | 2017 |
| 580 | ROSALIND | Investigating fibROmuscular dysplasia and spontaneous coronary Artery dissection using genetic and functionaL genomics to decipher the origIN of two female specific cardiovascular Diseases | 2017 |
| 581 | EPI-Centrd | Epilepsy Controlled with Electronic Neurotransmitter Delivery | 2017 |
| 582 | Des.solve | When solids become liquids: natural deep eutectic solvents for chemical process engineering | 2017 |
| 583 | INSOMNIA BEAT IT | Integrated Network of Sleep-Optimizing Modules for Norm-Informed Adaptive Behavioural, Environmental And Therapeutic Internet Training | 2017 |
| 584 | CoALIVE | Coenzyme A – Launch of In Vivo Experiments | 2017 |
| 585 | TreatStroke | arTificial neuRal nEtwork prediction of hAemorrhagic Transformation in STROKE. | 2017 |
| 586 | MILAS | MIcro-pulsed, diode-based LASer | 2017 |
| 587 | TheranOMICS | Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer | 2017 |
| 588 | BrainChip | Human on Chip : Microsensor unit and control algorithm integration for brain on a chip drug testing applications and development | 2017 |
| 589 | BCSC-ST | Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation | 2017 |
| 590 | Cytokineproteomics | Investigating inflammatory signaling by combining phospho- and ubiquitin proteomics with CRISPR/Cas9 technology | 2017 |
| 591 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 592 | OMICS | Origami-based Microfluidic Interface for Cell Signalling | 2017 |
| 593 | UBIMAPS | Ubiquitin-dependent regulation of the microtubule cytoskeleton | 2017 |
| 594 | LiSDMA | Liver steatosis drives muscle atrophy in type 2 diabetes patients. | 2018 |
| 595 | CRISTONE | Targeting CRISPR-based HDAC inhibitors to histones: a new tool for assessing mechanisms of class I HDAC inhibitors and developing chemical probes. | 2017 |
| 596 | GlycoNanoPep | Glyco and Nano Peptide Conjugates for Selective Cell Penetration | 2017 |
| 597 | ColoFILM | Multifunctional polymeric film-based drug delivery system for oral anti-TNF-alpha-based inflammatory bowel disease therapy | 2017 |
| 598 | PGXOME | A pharmacogenomic exploration of adverse drug reactions in epilepsy | 2017 |
| 599 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 600 | RHOMBOSMALPS | Enabling malaria rhomboid proteases as drug targets: usage of molecular cookie cutters to shape novel activity assays and inhibitors. | 2017 |
| 601 | CerebellumTherapy | Sensorimotor plasticity in the cerebellar microcircuit and its therapeutic potential | 2017 |
| 602 | MINERVA | MIcrobiota-Gut-BraiN EngineeRed platform to eVAluate intestinal microflora impact on brain functionality | 2017 |
| 603 | PROGLUTASIS | Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 |
| 604 | VALENCE-REPLAY | Disentangling amygdala contributions to replay-mediated, hippocampal-dependent memory consolidation | 2017 |
| 605 | PhoRAu | Photochemistry and radiolabelling of gold(III) anticancer prodrugs | 2018 |
| 606 | SupaSteD | Suppresion of adaptive immunity by the Salmonella effector SteD | 2017 |
| 607 | COV RESTRIC | Unravelling species barriers of coronaviruses | 2017 |
| 608 | ENDOCAM | TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES | 2017 |
| 609 | NANOCANCER | Getting new insights into the radio-sensitization effects of nanoparticles in photon and charged particle therapy | 2017 |
| 610 | DNAmethAML | Investigation of aberrant DNA methylation in malignant haematopoiesis | 2018 |
| 611 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
| 612 | HeartATAC | Epigenetic regulation of cardiac regeneration after injury. | 2017 |
| 613 | NanoALS | Nanoparticle-based immunization, a novel therapeutic strategy for amyotrophic lateral sclerosis | 2018 |
| 614 | OPN-Can | Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models | 2017 |
| 615 | MetaBiota | Crosstalk between microbiota metabolites and immune cells, the missing link to brain damage. | 2017 |
| 616 | IDRE | IMPACT OF DNA REPLICATION ON EPIGENETICS | 2017 |
| 617 | PhaseAge | The chemistry and physics of RNP granules: how they form, age and cause disease | 2017 |
| 618 | MArylAND | At the host-bacteria interface: Modulation of the intestinal microbiota and its metabolic activity by Card9 signalling in health and Inflammatory Bowel Diseases | 2017 |
| 619 | COTETHERS | Molecular characterization of vesicle tethering complexes as novel regulators of collagen trafficking | 2017 |
| 620 | iChip | Intestine-on-a-chip for investigating microbioal-epithelail interaction | 2018 |
| 621 | LIPMETIN-sURFing | Small open reading frames (smORF) as novel modulators of disorders of dietary excess | 2018 |
| 622 | HUNTINFISH | Generation of new zebrafish models for the study of the pathogenesis of Huntington´s disease and for the identification of new therapeutic targets. | 2018 |
| 623 | PROIRICE | Proton-Irradiated Ice: Dynamics and Chemistry from First Principles | 2017 |
| 624 | EXO-EYE | Stem Cell-Derived Exosomes for the treatment of Traumatic and Degenerative Eye Disease | 2017 |
| 625 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 626 | RTKPalm | Modulating and Profiling Receptor Tyrosine Kinase S-palmitoylation in Breast Cancer | 2017 |
| 627 | StressEBOV | Ebola virus manipulation of the cellular stress responses | 2017 |
| 628 | CATRATS | Catalytic Enantioselective Allene Cycloisomerisation Reactions for Alkaloid Total Synthesis | 2017 |
| 629 | BICEPSvsHIV | Novel strategies for anti-HIV-1 therapy: Small molecules targeting RNA partners of the nucleocapsid protein | 2017 |
| 630 | TNFaLysMyr | Unique TNFα lysine myristoylation; elucidating its function, regulation and integration into inflammation | 2018 |
| 631 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 632 | ACTrans | Accelerating Clinical Translation. Charting the Politics of Translation in the European Union | 2018 |
| 633 | MOOAC | Multi-compartmental Organ-on-a-Chip | 2018 |
| 634 | ECtomics | Dissecting spinal cord ependymal cell heterogeneity by single-cell transcriptomics | 2017 |
| 635 | mPOWER | Mobile platform to empower cancer patients with fatigue | 2017 |
| 636 | ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 | 2015 |
| 637 | IBiDT | Individualized Binaural Diagnostics and Technology | 2018 |
| 638 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
| 639 | EASY | Epigenetic approach for the treatment of obesity | 2017 |
| 640 | NanoZfish | Restoration of motor dysfunction in vivo through nanomaterials based devices | 2017 |
| 641 | VWF and NETs | Investigating the interplay between VWF, platelets, and neutrophil extracellular traps in pathologies involving thrombosis of the microvasculature | 2017 |
| 642 | MUC | The microbial degradation and utilization of mucin by Bacteroides in ulcerative colitis | 2017 |
| 643 | SAVE | Shear Stress Induced Arterial and Venous Specification through Piezo1 | 2018 |
| 644 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
| 645 | BioALFA | The effect of pro-aging and pro-youthful blood factors in normal ageing and Alzheimer’s disease: a multimodal approach | 2018 |
| 646 | Tau Seeding | Identification and validation of human proteins that control tau seeding in cell-based and in vivo models | 2017 |
| 647 | WHOLENICHE | Hold it or let it go: a niche decision on cancer growth | 2017 |
| 648 | ContraNPM1AML | Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia | 2017 |
| 649 | InflammaTENSION | A study of the roles of the immune and inflammatory systems in hypertension. | 2017 |
| 650 | e-walk | Biomechanical engineer for robotic healthcare solutions | 2017 |
| 651 | ISA-NPC-ASI | In Situ structural Analysis of Nuclear Pore Complex ASsembly Intermediates by cryo-FIB-tomography | 2018 |
| 652 | miRStem | Reprogramming of elite B cells to induced hematopoietic stem cell with microRNAs and transcription factors | 2017 |
| 653 | TSPBNTM | Tubular Supramolecular Polymer Brushes as Novel Therapeutic Materials | 2017 |
| 654 | M-DrivE | Metabolic Drivers of Epigenetic Modifications: metabolic inducers of histone post-translational modifications in a biological setting | 2018 |
| 655 | INIMUD | Impact of Neuromedin U in type 2 immunity and mucosal defence | 2017 |
| 656 | STARFISH DNA | Stalling the Replication Fork via the Impedimental Stabilization of Higher-order DNAs | 2017 |
| 657 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 658 | Signalling-in-NODs | Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation | 2017 |
| 659 | BaskAtax | Modulation of Basket cell microcircuits in cerebellar cortex paroxysmal ataxia disorders | 2017 |
| 660 | IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 | 2017 |
| 661 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
| 662 | INFISS | Targeting infertility associated to defective Insulin/IGF-1 signalling | 2017 |
| 663 | ENDODEP | Molecular mechanisms of endosome departure from the spindle in asymmetric cell division | 2017 |
| 664 | CFZEBRA | Balancing the immune response in cystic fibrosis: using zebrafish models of infection and inflammation to uncover new therapeutic approaches | 2017 |
| 665 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 666 | NICHOIDS | Nichoid: nanoengineered three-dimensional substrate for stem cell expansion | 2017 |
| 667 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 668 | NEST | Nanoengineering of radioactive seeds for cancer therapy and diagnosis | 2017 |
| 669 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 670 | CoaguPOC | SMART POINT-OF-CARE DEVICE FOR SELF-PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT THERAPY | 2017 |
| 671 | NGN-PET | Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments - Sofia ref.: 116072 | 2017 |
| 672 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 673 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
| 674 | TryptoBoost | Boosting tryptophan fluorescence with optical nanoantennas to watch label-free protein dynamics with single molecule resolution at high concentration | 2017 |
| 675 | COMBAT | Clearance Of Microbial Biofilms by Advancing diagnostics and Therapy | 2017 |
| 676 | REPRODAMH | Extra-gonadal roles of Anti-Müllerian Hormone in the aetiology of polycystic ovary syndrome: the domino effect to reproductive neuroendocrine dysfunctions | 2017 |
| 677 | GENDOSIS | GENOTYPE - ENDOPHENOTYPE ASSOCIATIONS IN PSYCHOSIS | 2017 |
| 678 | MMXVI | Minimal Model for Pox-Virus Infection | 2017 |
| 679 | MINDED | MultIscale precision therapies for NeuroDEvelopmental Disorders | 2018 |
| 680 | CORFEDITING | Gene Editing as Therapeutic Strategy for C9ORF72 Linked ALS/FTD | 2017 |
| 681 | DeShield | Hide and Seek with Cancer Drugs | 2017 |
| 682 | BETACONTROL | Control of amyloid formation via beta-hairpin molecular recognition features | 2017 |
| 683 | NAFLDcure | A novel pharmaceutical treatment for nonalcoholic fatty liver disease | 2017 |
| 684 | gdTCR-Ligand | Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy | 2017 |
| 685 | MetaboMARKER | A metabolism-based prognostic biomarker for prostate cancer | 2017 |
| 686 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
| 687 | MovEAID | A novel wearable medical device and eHealth system to improve the mobility of patients withhemiparesis | 2017 |
| 688 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 689 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 690 | KupfferCellNiche | Determining the instructive tissue signals and the master transcription factors driving Kupffer cell differentiation | 2017 |
| 691 | ImmuneCheckpointsAD | Immune checkpoint blockade for fighting Alzheimer’s disease | 2017 |
| 692 | SynPlex | Tailored chemical complexity through evolution-inspired synthetic biology | 2017 |
| 693 | NO-ESKAPE | Addressing Antibiotic Resistance: New Strategies for Overcoming the ESKAPE Pathogens | 2017 |
| 694 | GENSURGE | Designer recombinases for efficient and safe genome surgery | 2018 |
| 695 | Ub-BAC | Dissecting and targeting ubiquitin networks in the course of bacterial infections | 2017 |
| 696 | m1ARNA | Transcriptomic m1A - a new key player in the epitranscriptome arena | 2017 |
| 697 | CyberGenetics | Cybergenetics: Theory and Design Tools for Biomolecular Control Systems | 2017 |
| 698 | NEMESIS | Neuron/mast cell interactions in skin diseases | 2017 |
| 699 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 700 | ImmortaSTEM | ImmortaSTEM: Transient Immortalisation for Patient Stem Cell Expansion and Therapeutic Application | 2017 |
| 701 | NOVITREP | Novel viral therapy through targeting DNA repair | 2017 |
| 702 | MEDIRAD | Implications of Medical Low Dose Radiation Exposure | 2017 |
| 703 | RHYP | A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection | 2017 |
| 704 | PeptIn | employing protein aggregation as an antibacterial design strategy | 2017 |
| 705 | METAMAPPER | Super-resolution genomic mapping for the microbiome | 2017 |
| 706 | MilliDrop | New MilliDrop Analyzer: miniaturized and faster clinical microbiology testing in only one drop | 2017 |
| 707 | ThermalMR | Thermal Magnetic Resonance: A New Instrument to Define the Role of Temperature in Biological Systems and Disease for Diagnosis and Therapy | 2018 |
| 708 | TOLERANCE FOOTPRINT | Clonal Deletion versus Clonal Diversion: Footprints of Self-Tolerance in the T CellRepertoire | 2017 |
| 709 | TYPHI | From Typhoid Fever to Antimicrobial Mechanisms | 2017 |
| 710 | BioProbe-PIT | Local molecular profiling of tumor tissue sections: towards personalized immunotherapy | 2017 |
| 711 | BrainDrain | Translational implications of the discovery of brain-draining lymphatics | 2017 |
| 712 | CodeSphere | CodeSphere - Discovering Therapeutic Nanoparticles by Molecular Encoding | 2017 |
| 713 | BEEOXAL | Treatment against honeybee varroosis based on highly effective application of oxalic acid through sublimation | 2017 |
| 714 | SYN1002 | A New Therapeutic Option to Protect Central Nervous System against Acute Ischemic Stroke | 2017 |
| 715 | TAPAS | TArgeting Platelet Adhesion receptors in thrombosiS | 2018 |
| 716 | TRANSVAC2 | European Vaccine Research and Development Infrastructure | 2017 |
| 717 | Tumor-Treg-Targeting | Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours | 2018 |
| 718 | UbiCODE | European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets | 2018 |
| 719 | V-EPC | Inherited disfunctions of brain microcirculation | 2017 |
| 720 | ZEBRAONCOFISH | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2017 |
| 721 | BrainEnergy | Control of cerebral blood flow by capillary pericytes in health and disease | 2017 |
| 722 | CADENCE | Catalytic Dual-Function Devices Against Cancer | 2017 |
| 723 | EuroNeurotrophin | A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation | 2018 |
| 724 | HYBRID | Innovative Training Network towards raising and supporting the next generation of creative and entrepreneurial cross-speciality imaging experts | 2017 |
| 725 | META-CAN | Targeting the metabolism-immune system connections in Cancer | 2017 |
| 726 | PD UpReg | Gene knock-up via 3’UTR targeting to treat Parkinson’s disease | 2017 |
| 727 | SAFER | Selective Agonists For Serotonin Receptors | 2017 |
| 728 | STARDUST | in vivo optogeneticS, elecTrophysiology and phArmacology with an ultRasonically-powered DUST for Parkinson's Disease | 2017 |
| 729 | TRAIN-EV | Training in Extracellular Vesicles: for benefit in Health and Disease | 2017 |
| 730 | EVICARE | Extracellular Vesicle-Inspired CArdiac Repair | 2017 |
| 731 | LUPUSCARE | PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | 2017 |
| 732 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 733 | NANOSTEM | New nanomaterials for neural stem cells drug delivery | 2018 |
| 734 | LightDyNAmics | DNA as a training platform for photodynamic processes in soft materials | 2018 |
| 735 | A4B | Analytics for Biologics | 2017 |
| 736 | DRIVE | Driving next generation autophagy researchers towards translation | 2017 |
| 737 | GLIOTRAIN | Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | 2017 |
| 738 | GET-UP BAT | GPCR Exploitation To Unlock the Power of Brown/Beige Adipose Tissue | 2017 |
| 739 | RTCure | Rheuma Tolerance for Cure | 2017 |
| 740 | ENTRANCE | Developing the iTOP kit: Empowering scientists with efficient intracellular delivery of biologicals in hard-to-manipulate cell types | 2017 |
| 741 | DecodingInfection | Decoding the host-pathogen interspecies crosstalk at a multiparametric single-cell level | 2017 |
| 742 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
| 743 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 744 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 745 | VitASTEM | Regulation of Single Hematopoietic Stem Cells by Intake of Vitamin A | 2018 |
| 746 | FAITh | Fighting Anxiety with Importin-based Therapeutics | 2017 |
| 747 | REVERSEAUTISM | Probing the Reversibility of Autism Spectrum Disorders by Employing in vivo and in vitro Models | 2017 |
| 748 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 749 | AstroNeuroCrosstalk | Astrocyte-Neuronal Crosstalk in Obesity and Diabetes | 2018 |
| 750 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 751 | NEBULAR | Novel Blueprints for the Visible-Light-Mediated Assembly of C–N Bonds via Nitrogen Radicals | 2018 |
| 752 | NEIMO | Neuronal regulation of immunity | 2017 |
| 753 | SUGARCODING | The neuroenergetics of memory consolidation – hybrid PET/MR imaging of the default mode network | 2018 |
| 754 | STARSTEM | NanoSTARS imaging for STEM cell therapy for arthritic joints | 2018 |
| 755 | SilkFUSION | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research | 2017 |
| 756 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 757 | safenolaTiCancerDrug | Highly and Widely Effective, Water Stable, and Non Toxic Titanium-Phenolato-based Anticancer Chemotherapy | 2017 |
| 758 | COMBACTE-CDI | Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections | 2017 |
| 759 | EDIReX | EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts | 2018 |
| 760 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 761 | SAVEBRAIN | Proof of principle for a first in class neuroprotective therapy in stroke and other acute neurodegenerative conditions | 2018 |
| 762 | 5D Heart Patch | A Functional, Mature In vivo Human Ventricular Muscle Patch for Cardiomyopathy | 2017 |
| 763 | NO-STRESS | Nitric oxide regulation of repolarisation in the heart: role of mechanical stress | 2018 |
| 764 | TENSION | Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial | 2018 |
| 765 | MOODSTRATIFICATION | Immune Signatures for Therapy Stratification in Major Mood Disorders | 2018 |
| 766 | UshTher | Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB | 2018 |
| 767 | COLOSSUS | Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | 2018 |
| 768 | EURO SHOCK | Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock | 2018 |
| 769 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
| 770 | TUDCA-ALS | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) | 2018 |
| 771 | RECOMB | Stem-cell based gene therapy for recombination deficient SCID (RECOMB) | 2018 |
| 772 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 773 | OligoGpivotalCF | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | 2018 |
| 774 | TAXINOMISIS | A multidisciplinary approach for the stratification of patients with carotid artery disease | 2018 |
| 775 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 776 | DIAMONDCOR | A molecular approach to treat diabetes mellitus onset dependent coronaropathy | 2018 |
| 777 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 778 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 779 | PredictingPain | Deconstructing pain with predictive models: from neural architecture to pain relief | 2018 |
| 780 | DRIVE | GUIDANCE AND FUNCTION OF REGENERATIVE FIBERS IN ADULT CNS | 2018 |
| 781 | ANTIViR | Molecular mechanisms of interferon-induced antiviral restriction and signalling | 2017 |
| 782 | MODVASC | Endothelial RNA Modifications in Vascular Homeostasis and Disease | 2018 |
| 783 | STRATO | Stress as a modifier of atherosclerosis - Novel mechanistic insights and therapeutic avenues - | 2018 |
| 784 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 785 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 786 | MRI4DEEG | An EEG calibration toolkit for monitoring rehabilitation of stroke patients. | 2018 |
| 787 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 788 | NO PROBleMS | Nourishing PRObiotics to Bees to Mitigate Stressors | 2018 |
| 789 | Nano-OligoMed | Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications | 2017 |
| 790 | RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION | 2018 |
| 791 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 792 | NEOMENTO | Redefining Virtual Reality Therapy for Anxiety Disorders | 2017 |
| 793 | MERLIN | Multi-modal, multi-scale retinal imaging | 2017 |
| 794 | ABC-S | Acoustic Blood Cells Sorter | 2018 |
| 795 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 796 | NANOSTORM | Design of Nanomaterials for Targeted Therapies Guided by Super Resolution Imaging | 2018 |
| 797 | MRS in diabetes | Novel methods in Magnetic Resonance Spectroscopy to investigate mechanisms underlying metabolic disease | 2018 |
| 798 | Damocles | Modelling brain aneurysm to elucidate the role of platelets | 2018 |
| 799 | SUMMA | Stimulating mir-106b expression to regenerate the myocardium | 2018 |
| 800 | CMTaaRS | Defective protein translation as a pathogenic mechanism of peripheral neuropathy | 2018 |
| 801 | NonChroRep | Investigating the role of the long noncoding transcriptome in chromatin replication | 2018 |
| 802 | HINBOTS | Highly Integrated Nanoscale Robots for Targeted Delivery to the Central Nervous System | 2018 |
| 803 | XHaLe | Hanover experimental lung research project | 2018 |
| 804 | Living Bionics | Living bioelectronics: Bridging the interface between devices and tissues | 2018 |
| 805 | CLLCLONE | Harnessing clonal evolution in chronic lymphocytic leukemia | 2018 |
| 806 | JUMPAIR | Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers | 2018 |
| 807 | Nanodevice | Nanostructure-based label-free biomolecular binding kinetics assay | 2018 |
| 808 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 809 | CROSS-NEUROD | Transferring autonomous and non autonomous cell degeneration 3D models between EU and USA for development of effective therapies for neurodegenerative diseases (ND) | 2018 |
| 810 | MARSI | Disruptive technologies for effectively rehabilitating chronic ambulatory disability | 2018 |
| 811 | SI | Structural and functional characterization of the ICOS/ICOSL immune complex | 2018 |
| 812 | REMATCH | Image-based analysis for drug discovery and repurposing | 2018 |
| 813 | TCAPS | mRNA cap regulation and function in CD8 T cells | 2018 |
| 814 | CLAUSTRUM | The Claustrum: A Circuit Hub for Attention | 2018 |
| 815 | ForceMorph | The integration of cell signalling and mechanical forces in vascular morphology | 2018 |
| 816 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 817 | iPS-ChOp-AF | Combining induced pluripotent stem cells, tissue engineering, optogenetic and chemogenetic concepts for the study and treatment of atrial fibrillation | 2018 |
| 818 | SaveHER | The inhibition of sorting proteins as a therapeutic avenue in HER2 positive breast cancer | 2018 |
| 819 | BIONICS | A biomimetic and neuroprotective delivery nanocapsule for the targeted treatment of post-ischemic stroke effects | 2018 |
| 820 | mABSPN | Antibody-based therapy against Streptococcus pneumoniae | 2018 |
| 821 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
| 822 | INSPIRE | Instrument Shape Sensing for Minimally Invasive Interventions | 2018 |
| 823 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 824 | SplicEcomplex | Deciphering the structure and dynamics of the early spliceosome assembly | 2018 |
| 825 | DREAMY | Disrupting Aberrant Protein–Protein Interactions with Conformationally Constrained Hydrocarbon α-Helical Mimetics | 2018 |
| 826 | ROCKSOFT | Rho GTPase cross-talk with syndecan-4 regulates pro-fibrotic mechanotransduction in the heart | 2019 |
| 827 | FINDER | FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction | 2018 |
| 828 | MaGMa | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | 2018 |
| 829 | TOPNIN | Tracing of pulmonary neuro-immune networks | 2018 |
| 830 | BEAT | regulation of B-cell Epitope migration and Autoimmunity by T follicular helper cells | 2018 |
| 831 | BOMB | Multi-scale BiOmechanical characterization of peri-iMplant Bone tissue: influence of the environment | 2018 |
| 832 | CENTR-ALL | Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) | 2019 |
| 833 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 834 | CheSSTaG | Chemotactic Super-Selective Targeting of Gliomas | 2018 |
| 835 | CORLINK | The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease. | 2019 |
| 836 | CRISPR-GQ | Identifying the Capabilities and Limitations of CRISPR in Targeting G-quadruplex Forming Sequences: From Target Recognition to Gene Expression Regulation | 2018 |
| 837 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 838 | CXCR4THERAPY | IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION | 2018 |
| 839 | ELECNANO | Electrically Tunable Functional Lanthanide Nanoarchitectures on Surfaces | 2018 |
| 840 | EnCAge | Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis | 2020 |
| 841 | Healing Encounters | Healing Encounters: Reinventing an indigenous medicine in the clinic and beyond | 2018 |
| 842 | MyelinPlasticity | Neuronal regulation of CNS myelin plasticity | 2018 |
| 843 | NoMePaCa | Novel Metabolic Pathways in Cancer | 2018 |
| 844 | EScORIAL | Emerging Simplex ORigins In ALS | 2018 |
| 845 | UB-RASDisease | The ubiquitin system in RAS-driven disease | 2018 |
| 846 | MicroC | Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance | 2018 |
| 847 | MoViS | An innovative screening protocol device for early identification of neonates at high-risk for Autism Spectrum Disorders | 2018 |
| 848 | NanoMop | Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C | 2018 |
| 849 | SCCMMI | Single cell correlates of memory, motivation and individuality | 2018 |
| 850 | REPROGRAMIT | Control of T cell differentiation and plasticity through mitochondrial reprogramming | 2019 |
| 851 | VALSL | Valorisation of splice-switching oligonucleotides for lung cancer therapy | 2018 |
| 852 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 853 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 854 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 855 | ASTRO_ECM | Deciphering the role of astrocytes in chronic depression. | 2018 |
| 856 | NeuPES | Inducing Neural Plasticity Using Electrical Stimulation Delivered by Nano-Structured Electrodes: A Critical Step Toward Post-Stroke Recovery | 2018 |
| 857 | NanoFEITH | Nanoparticles for Fluorescence-Enhanced Imaging and Therapy of Breast Cancer | 2018 |
| 858 | TREGinAD | Role of Aβ Specific Regulatory T cells in harnessing cerebral Aβ clearance in Alzheimer’s Disease | 2018 |
| 859 | ORTHOCAT | Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs | 2018 |
| 860 | TELIOTES | Thermal and ELectronic Transport in Inorganic-Organic ThermoElectric Superlattices | 2018 |
| 861 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 862 | REPTOL | Pre-leukemic B cell repertoire alterations in patients with familial chronic lymphocytic leukemia: looking for evidence of a genetically-inherited defect in tolerance induction | 2019 |
| 863 | NEUROTARGET | Treatment of traumatic brain injury using dye-loaded polymeric nanoparticles | 2018 |
| 864 | FA x Force | Reconstitution and Structural Analysis of a Minimal Mechanosensitive Focal Adhesion Complex | 2019 |
| 865 | AMNEsIA | Interactions of amyloid peptides with the neuronal membrane interface: molecular mechanisms involved in Alzheimer’s disease | 2018 |
| 866 | FLYMEN | A Drosophila model for understanding the basis of Meniere’s disease | 2019 |
| 867 | VIAR | Virus-induced autophagy restriction | 2018 |
| 868 | SinMolTermination | Single-molecule visualisation of eukaryotic DNA replication termination to uncover novel mechanisms of replication stress | 2019 |
| 869 | PREMEDiCARE | PREcision MEDicine with induced pluripotent stem cells for Cardiac Arrhythmias Risk Evaluation | 2018 |
| 870 | ONCOTHERANOSTICS | Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. | 2019 |
| 871 | MATRIX-B | Triaxial Magnetic Fields for the Control of Bioactive Materials in Bone Engineering | 2018 |
| 872 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 873 | HTS-STABTHERAPRO | High-throughput directed evolution to engineer thermostable therapeutic proteins | 2018 |
| 874 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 875 | MTOAC | Multi-compartmental Tumor-on-a-Chip | 2018 |
| 876 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 877 | PFC-AMY | Functional networks underlying emotion processing | 2018 |
| 878 | MECoCaM | Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. | 2018 |
| 879 | SOCIALBRAINCIRCUITS | Neuroanatomical substrates of social deficit in a mouse model of 22q11 deletion syndrome | 2018 |
| 880 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
| 881 | SPArKLE | New players in immunometabolism: investigating the role of succinate and pyruvate kinase in T cell immunity | 2018 |
| 882 | GlycoPCs | How do Pharmacological Chaperones work? Molecular basis of the actions of glycomimetics on keyglycosidases involved in lysosomal storage disorders | 2018 |
| 883 | DETRIMODE | DEgradation TRIggered by MOdular DEsign | 2018 |
| 884 | MITOPOMPE | Targeting mitochondrial defects and oxidative stress in Pompe Disease: from pathogenesis to therapy | 2019 |
| 885 | MECHANOIDS | Probing and controlling the three-dimensional organoid mechanobiology | 2019 |
| 886 | IMPACT-HEALTH | IMaging Pancreatic Alpha-cells Calcium Tied with HEterogeneous Analysis of Labeled Transcription factors with in situ Hybridization | 2018 |
| 887 | Multiple Sclerosis | Development of a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis | 2018 |
| 888 | NeuroVU | NeuroVU: Real-time Sensing in Microfluidic Models of the Neurovascular Unit | 2018 |
| 889 | Striking streaks | Invariant Natural Killer T-cells in atherogenesis | 2018 |
| 890 | SKIN SUBSTITUTE | Development of hybrid artificial skin substitute for chronic diabetic wounds | 2018 |
| 891 | IMM-GNRs | Human IMMune profiling of Graphene NanoRibbons | 2018 |
| 892 | 3DPRINT-VASCU-CHIP | 3D Printed Vascular Model-on-Chip Platform with Automated Customization | 2018 |
| 893 | MRI COMIQSUM | MRI COntrast using MIcrobubbles in Quantitative SUsceptibility Mapping | 2018 |
| 894 | Rotaxane-DNA | Rotaxane-Oligonucleotides: Stimuli-Responsive Mechanically Interlocked Architectures to Control Oligonucleotide Activity and Gene Transcription | 2018 |
| 895 | MECHANOSITY | Mechanical regulation of cellular behaviour in 3D viscoelastic materials | 2019 |
| 896 | RE-IMMUNE | Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer | 2019 |
| 897 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 898 | AstroMiRimage | Super-resolution imaging to uncover microRNA control of astrocytes in epilepsy | 2018 |
| 899 | Gut_Fights_PD | Investigating protective mechanisms of gut bacteria in C. elegans models of Parkinson’s disease | 2019 |
| 900 | GEMZ | Genetic Epilepsy Models in Zebrafish | 2019 |
| 901 | UNNAMEd-2 | Unraveling the conceptional novel ADAM17 regulation by PP2A in metastasis formation. | 2019 |
| 902 | MemCHAPS | Intramembrane chaperones : their role in folding membrane proteins | 2019 |
| 903 | Neuronetmir | Role of miR-129-5p and Rbfox1 crosstalk in neural network homeostasis | 2018 |
| 904 | Newron-TBI | Neurogenesis-related changes in hippocampal new neurons and circuits after traumatic brain injury | 2018 |
| 905 | NEVULA | Understanding selective neuronal vulnerability in Alzheimer’s disease | 2018 |
| 906 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
| 907 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 908 | PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) | 2018 |
| 909 | EyeTREAT | Innovative tool for personalized treatment of patients with neovascular age-macular degeneration: dosage optimization for long term efficacy treatment | 2018 |
| 910 | NeuroRBP | Studying RNA-binding proteins involved in neural differentiation and degeneration | 2019 |
| 911 | PCaProTreat | Multi-omics molecular treatment targets for Prostate Cancer | 2018 |
| 912 | TAMYOCAL | Tamoxifen mediated protection on X-linked centronuclear myopathy: a mechanistic and pre-clinical study | 2018 |
| 913 | PROCHIP | Chromatin organization PROfiling with high-throughput super-resolution microscopy on a CHIP | 2018 |
| 914 | PFS | A cost- energy-efficient treatment technology to remove pharmaceutical pollutants from water | 2018 |
| 915 | METAdiag | Detecting serious diseases due to abnormal cellular energetics | 2018 |
| 916 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 917 | BIORIMA | BIOmaterial RIsk MAnagement | 2017 |
| 918 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 919 | THERACAT | Bio-orthogonal catalysis for cancer therapy | 2018 |
| 920 | GENOMIA | Genomic Modifiers of Inherited Aortapathy | 2019 |
| 921 | IMI-PainCare | Improving the care of patients suffering from acute or chronic pain | 2018 |
| 922 | mitozippers | Mitochondrial membrane-targeted compounds for cancer therapy | 2018 |
| 923 | POLICE | The PIDDosome in Centrosome and Ploidy-Surveillance | 2018 |
| 924 | C-CLEAR | Complement: to clear or not to clear | 2018 |
| 925 | Paget-Advance | Advancing knowledge to improve outcome in Paget’s disease of bone | 2018 |
| 926 | DRAIOCHT | DRAIOCHT- A low-cost minimally invasive platform medical device for the treatment of disorders of the cardiovascular system. | 2019 |
| 927 | CardHeal | Novel strategies for mammalian cardiac repair | 2018 |
| 928 | ProgrES | Programmable Enzymatic Synthesis of Bioactive Compounds | 2018 |
| 929 | SENSATIONAL TETHERS | Tethers for sensory mechanotransduction: from molecules to perception | 2018 |
| 930 | LABPATCH | Lab-in-a-patch for PKU self-assessment | 2018 |
| 931 | CERVINO | Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics? | 2018 |
| 932 | mTORmorS | Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma | 2019 |
| 933 | CoDEC | Decoding the development of physiologic and epileptic cognitive neural networks | 2018 |
| 934 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 935 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 936 | BioWings | Bio-compatible electrostrictive smart materials for future generation of medical micro-electro- mechanical systems | 2018 |
| 937 | evFOUNDRY | The Extracellular Vesicle Foundry | 2018 |
| 938 | RESCUE | Local Training Network on REgenerative medicine and Stem Cell technology in UtrEcht | 2018 |
| 939 | LeiSHield-MATI | A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis | 2018 |
| 940 | HOPE | Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 | 2018 |
| 941 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 942 | DYNACOTINE | Signal transduction and allosteric modulation of nicotinic acetylcholine receptors:from ion channel electrophysiology to atomic 3D structures | 2019 |
| 943 | ENVISION | Novel mechanisms of early defense against virus infections | 2018 |
| 944 | DISCOVER | Death receptor signalling in tumour immune editing | 2018 |
| 945 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 946 | GI-BCT | Disruptive imaging technology for accurate and painless breast cancer diagnosis | 2018 |
| 947 | AllergyExplorer | Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results | 2018 |
| 948 | Gut_Fights_PD | Investigating protective mechanisms of gut bacteria in C. elegans models of Parkinson’s disease | 2019 |
| 949 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 950 | TRILLIO | TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases | 2018 |
| 951 | ASSYSt | A reliable CXCL4 biomarker assay to improve diagnosis and treatment of Systemic Sclerosis | 2018 |
| 952 | PROCEED | Proteomics for Chronic Kidney Disease Therapy | 2018 |
| 953 | Achilles | Overcoming specific weaknesses in tendon biology to design advanced regenerative therapies | 2018 |
| 954 | TLA-Gut | Novel Personalized Cellular Therapy Approach for Immune Diseases | 2018 |
| 955 | PAH-HOPE | New hope for the PAH patient: A Novel Therapeutic for Pulmonary Arterial Hypertension (PAH) | 2018 |
| 956 | STstent | Short Term Stent - A composite removable sinus stent for functional endoscopic sinus surgery that improves patient outcomes and reduces revision surgeries | 2018 |
| 957 | QTrobot | QTrobot Autism Therapy Store | 2018 |
| 958 | PhagoPROD | GMP manufacturing & GLP diagnostic: Towards a personalised phage therapy against antimicrobial resistance | 2018 |
| 959 | MycoRailway | Discovery and molecular investigation of mycobacterial transporters responsible for iron acquisition | 2018 |
| 960 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
| 961 | FlexiBiome | Next Generation Microbiome Platform | 2018 |
| 962 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
| 963 | Oncarin | A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer | 2018 |
| 964 | LYSADERM | Platelet LYSAte based DERMal formulation for the treatment of skin ulcers | 2018 |
| 965 | SWIRL | Short, weakly interacting RNA ligands for the development of high-concentration monoclonal antibody therapeutics | 2018 |
| 966 | EFOEUPATI | Ensuring the future of EUPATI beyond 2020 | 2018 |
| 967 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
| 968 | ACORN | Nanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing Molecules | 2018 |
| 969 | PLATELYS | PlateLys: The innovative human platelet lysate especially designed to maximize the effectiveness of cell-based therapies | 2018 |
| 970 | 2shRNA | 2shRNA branched nanobinders as promising therapeutic tools for combined cancer therapy | 2019 |
| 971 | TRIM-NET | Training network in drug discovery targeting TRIM Ubiquitin ligases in disease | 2019 |
| 972 | ChromDesign | Chromatin architecture and Design | 2018 |
| 973 | NEVADA | Novel microengineered environments for mouse embryonic stem cell (mESC) differentiation towards cardiomyocytes | 2018 |
| 974 | EVOdrops | directed EVOlution in DROPS | 2018 |
| 975 | V.A. Cure | A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies | 2019 |
| 976 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 977 | ARTTOUCH | Generating artificial touch: from the contribution of single tactile afferents to the encoding of complex percepts, and their implications for clinical innovation | 2019 |
| 978 | SOMIT | Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease | 2018 |
| 979 | CICURE | Increasing complex I stability as a cure for mitochondrial diseases | 2018 |
| 980 | HISTOID | A Human iPS Cell-Derived Artificial Skeletal Muscle for Regenerative Medicine, Disease Modelling and Drug Screening | 2018 |
| 981 | PML-THERAPY | HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 |
| 982 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 983 | Treat-HSP | Development of new therapy for rare motor neuron diseases | 2018 |
| 984 | NanoCarb | Glyco-Nanoparticles for Applications in Advance Nanomedicine | 2018 |
| 985 | NanoPol | Soft Biocompatible Polymeric Nanostructures: A Toolbox for Novel Generation of Nano Pharmaceuticals in Ophthalmology | 2019 |
| 986 | CereBrill | Brain training tools for better focus - using games and brainwaves to improve performance in children with ADHD | 2018 |
| 987 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 988 | STINTS | Skin Tissue INTegrity under Shear | 2019 |
| 989 | Syn2Psy | Synaptic Dysfunction in Neuropsychiatric Disorders | 2019 |
| 990 | synBIOcarb | Synthetic biology of carbohydrate-binding proteins: engineering protein-carbohydrate interactions for diagnostics and cell targeting | 2018 |
| 991 | PEP-NET | Predictive Epigenetics: Fusing Theory and Experiment | 2018 |
| 992 | MOAB | Miniaturised optically accessible bioreactor for drug discovery and biological research | 2018 |
| 993 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 994 | BestTreat | BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease | 2018 |
| 995 | RxmiRcanceR | Tumor suppressive microRNAs for cancer therapy | 2018 |
| 996 | PROVEC | Promoting Osteogenesis through Vascular Endothelial Cells | 2019 |
| 997 | LIFT | Liquid Foam Therapy (LIFT) for Acute Respiratory Distress Syndrome (ARDS) | 2018 |
| 998 | STACCATO | European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis | 2019 |
| 999 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
| 1000 | pHioniC | pH and Ion Transport in Pancreatic Cancer | 2018 |
| 1001 | TREAT-PD | Patient-specific treatment for Parkinson's disease using reprogrammed skin cells | 2018 |
| 1002 | VIRUSES AND RNA | RNA regulation during viral infection | 2019 |
| 1003 | DYNACEUTICS | Remote control healing: Next generation mechano-nano-therapeutics | 2019 |
| 1004 | EcoBox | Ecosystem in a box: Dissecting the dynamics of a defined microbial community in vitro | 2019 |
| 1005 | WHILYAS | Wound healing ILYA-style | 2018 |
| 1006 | DiRECT | Directly reprogrammed renal cells for targeted medicine | 2019 |
| 1007 | VITAE | VIrTual BrAin PErfusion: Assessing cerebrovascular function by High Performance Computing from 3D brain vessel network data for vascular-targeted drug development in neurodegenerative diseases. | 2018 |
| 1008 | CANCER INVASION | Deciphering and targeting the invasive nature of Diffuse Intrinsic Pontine Glioma | 2019 |
| 1009 | RiboInflam | Assessing the role of ribosomes and mRNA translation in shaping the inflammatory response | 2019 |
| 1010 | FunHoMic | Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections | 2019 |
| 1011 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 1012 | CONNECT | Connecting neural networks: Nervous-system-on-Chip Technology | 2019 |
| 1013 | EBRA | European Brain Research Area | 2018 |
| 1014 | iProg | Tailored cell-based therapies for frontotemporal dementia and related genetically defined CNS orphan indications | 2018 |
| 1015 | IRL790 | NOVEL THERAPEUTIC FOR THE TREATMENT OF PARKINSONS DISEASE | 2018 |
| 1016 | LIPOBITS | Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) | 2018 |
| 1017 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
| 1018 | TRICARIX | Minimally invasive transcatheter system for tricuspid heart valve replacement | 2018 |
| 1019 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 1020 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 1021 | RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials | 2019 |
| 1022 | ENDOSCAPE | ENDOSCAPE, a clinically applicable non-viral gene delivery technology | 2019 |
| 1023 | iP-OSTEO | Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds | 2019 |
| 1024 | ERINHA-Advance | Advancing European Research Infrastcuture on Highly Pathogenic Agents | 2019 |
| 1025 | VeCare | Selective retention of VEGF for cancer and retinopathies therapeutics | 2019 |
| 1026 | Filterlex | Filterlex is a unique, full-body, embolic protection device for Trans-catheter Aortic Valve Implantation procedures. | 2018 |
| 1027 | SM-Epigen | Revealing the Epigenetic Regulatory Network with Single-Molecule Precision | 2018 |
| 1028 | PedSarc | Targeting genetic and epigenetic mechanisms in pediatric sarcomas. | 2019 |
| 1029 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 1030 | DiSCo MRI SFN | Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging | 2019 |
| 1031 | C-MORPH | Noninvasive cell specific morphometry in neuroinflammation and degeneration | 2018 |
| 1032 | PHARMS | Bacteriophage inhibition of antibiotic-resistant pathogenic microbes and founding for novel therapeutic strategies | 2019 |
| 1033 | DDRMac | DNA Damage Response-instructed Macrophage Differentiation in Granulomatous Diseases | 2019 |
| 1034 | CuRE | Cardiac REgeneration from within | 2019 |
| 1035 | Combat_ALS | Development of new chemical tools to combat ALS | 2019 |
| 1036 | MegaALS | Unravelling the Interplay between Metabolism, Gut Microbiome and Adaptive Immunity in Amyotrophic Lateral Sclerosis | 2018 |
| 1037 | TinniMizer | TinniMizer : A Patient-specific Novel Approach for Tinnitus Treatment | 2018 |
| 1038 | inCITe | Seeing Citrulline: A Molecular Toolbox for Peptidyl Arginine Deiminases | 2019 |
| 1039 | LeukemiaEnviron | SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA | 2019 |
| 1040 | HTx | Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe | 2019 |
| 1041 | CancerQR | Next generation cancer therapies targeting cancer networks | 2019 |
| 1042 | RADAR-AD | Remote Assessment of Disease and Relapse – Alzheimer’s Disease | 2019 |
| 1043 | iPSpine | Induced pluripotent stem cell-based therapy for spinal regeneration | 2019 |
| 1044 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 1045 | HiMISER | High resolution Miniature Implantable nerve Stimulator for Electroceutical Research (HiMISER) | 2019 |
| 1046 | KING | An avant-garde measuring principle based on the potentiometric method using signals from the kidney to monitor hospitalised patients water-volemic state | 2018 |
| 1047 | IntegraBrain | Integrated Implant Technology for Multi-modal Brain Interfaces | 2019 |
| 1048 | RESTORE | User-centred smart nanobiomaterial-based 3D matrices for chondral repair | 2019 |
| 1049 | MycoVAP | Bacterial chassis for treating ventilator-associated pneumonia (VAP) | 2019 |
| 1050 | SmartEater | Enhancing recovery from eating and weight disorders using mHealth and psychological theory | 2019 |
| 1051 | CardioReGenix | CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease | 2019 |
| 1052 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 1053 | SOLID | Suppression of Organelle Defects in Human Disease | 2019 |
| 1054 | ENDOMICS | Raman Endoscopic Proteo-lipidomics of Bladder Cancer | 2019 |
| 1055 | The MATRIX | Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype? | 2019 |
| 1056 | EpiTune | Epigenetic fine-tuning of T cells for improved adoptive cell therapy | 2019 |
| 1057 | Homo.symbiosus | Assessing, preserving and restoring man-microbes symbiosis | 2019 |
| 1058 | NEUROPRECISE | Precision medicine in traumatic brain injury using individual neurosteroid response | 2019 |
| 1059 | EPIORGABOLISM | Diabetic nephropathy modelling in hESC-derived 3D kidney organoids | 2019 |
| 1060 | IMMCEPTION | Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation | 2019 |
| 1061 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
| 1062 | FutureTrophicFactors | Elucidating therapeutic effects and mode of action of future trophic factorsin ALS and Parkinson’s disease | 2019 |
| 1063 | STICK2HEAL | Innovative adhesives for ear drum healing | 2019 |
| 1064 | incPRINT-DRUG | incPRINT as a platform for RNA-targeted drug discovery | 2019 |
| 1065 | GLADIATOR | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | 2019 |
| 1066 | NeuroStimSpinal | A STEP FORWARD TO SPINAL CORD INJURY REPAIR USING INNOVATIVE STIMULATED NANOENGINEERED SCAFFOLDS | 2019 |
| 1067 | TopSpec | Next generation precision antibody profiling - from science fiction to reality | 2019 |
| 1068 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 1069 | PUPILTRAITS | Biomarkers of individual differences in human cortical visual processing | 2019 |
| 1070 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 1071 | ReSpire | Respirable Advanced Therapeutics for Cystic Fibrosis & other Lung Diseases | 2019 |
| 1072 | Vezics | Highly efficient, scalable chromatography platform for high-quality exosome isolation | 2019 |
| 1073 | Rhythm and Brains | How musical rhythm moves humans: functionalmechanisms of entrainment and perception-action coupling | 2019 |
| 1074 | ENTRI | Enteric-nervous-system-mediated regulation of intestinal inflammation | 2019 |
| 1075 | BRITE | Elucidating the molecular mechanisms underlying brite adipocyte specification and activation | 2019 |
| 1076 | WATCH | Well-Aging and the Tanycytic Control of Health | 2019 |
| 1077 | ArthritisHeal | Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis | 2019 |
| 1078 | SUMMIT | Site-specific Ultrasensitive Magnetic resonance of Mixtures for Isotopic Tracking | 2019 |
| 1079 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 1080 | PROTONMBRT | Spatial fractionation of the dose in proton therapy: a novel therapeutic approach | 2019 |
| 1081 | Epi4MS | Targeting the epigenome: towards a better understanding of disease pathogenesis and novel therapeutic strategies in Multiple Sclerosis | 2019 |
| 1082 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
| 1083 | ImmuNiche | Identifying spatial determinants of immune cell fate commitment | 2019 |
| 1084 | STEP 2 | Spatiotemporal regulation of T-cell Priming | 2019 |
| 1085 | iHEAR | Gene therapy of inherited and acquired hearing loss | 2019 |
| 1086 | PACA-MET | Genome-wide surveys and functional analysis of pancreatic cancer metastasis drivers | 2019 |
| 1087 | ONCOFUM | Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition | 2019 |
| 1088 | ProMiDis | A unified drug discovery platform for protein misfolding diseases | 2019 |
| 1089 | OrganoPlate Graft | Organ-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissues | 2019 |
| 1090 | DIAIoT | An e-Health expert system for diagnosis and treatment of diabetics to reduce the risk of skin breakdown and co-existing foot diseases | 2019 |
| 1091 | Pictogram | Pictogram: a Digital Environment for Autism Spectrum Disorder Treatment & Management | 2019 |
| 1092 | FIRM | Form and Function of the Mitochondrial Retrograde Response | 2019 |
| 1093 | DNACom | Compartmentalized DNA Computers for In-Vitro Diagnostic Applications | 2019 |
| 1094 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 1095 | POCON | Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development | 2019 |
| 1096 | RESOLVE | tPA-Nanoconstructs for Treating Acute Ischemic Stroke: a Technical and Commercial Analysis | 2019 |
| 1097 | SQP | Opening new markets for Single Quantum Photodetectors | 2019 |
| 1098 | RecoverInFlame | T cell-driven inflammatory mechanisms promote recovery after acute brain injury | 2018 |
| 1099 | mitoUPR | Cellular modulation by the mitochondrial unfolded protein response | 2019 |
| 1100 | ReCoDE | Reshaping cortical circuits to decrease binge eating | 2019 |
| 1101 | RAPID | RAPID MIGRAINE RELIEF WITH ALGINATE-BASED THIN FILM | 2018 |
| 1102 | VESSEL CO-COPTION | Vessel co-option and radioresistance in glioblastoma | 2019 |
| 1103 | METAPTPs | PROTEIN TYROSINE PHOSPHATASES IN METABOLIC DISEASES: OXIDATION, DYSFUNCTION AND THERAPEUTIC POTENTIAL | 2019 |
| 1104 | PRO-TOOLKITS | Programmable nucleic acid toolkits for cell-free diagnostics and genetically encoded biosensing | 2019 |
| 1105 | iDysChart | Charting key molecules and mechanisms of human immune Dysregulation | 2019 |
| 1106 | EUCANCan | EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. | 2019 |
| 1107 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
| 1108 | RGD-Diabetes | Development of RGD-therapeutics for cardio-metabolic disease | 2019 |
| 1109 | GSYNCOR | Graphene-syncronized coherent Raman scattering laser and microscope | 2019 |
| 1110 | INHuMAN | Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma | 2019 |
| 1111 | CVD_CysSSSCys | Investigating the Therapeutic Potential of Persulfides: Implications of their Roles in Cardiovascular Disease | 2019 |
| 1112 | HepEDOT | Conductive, self-doping and biodegradable oligoEDOT-heparin biomaterial for improved electromechanical coupling, cardiac cell retention and delivery of paracrine factors | 2019 |
| 1113 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 1114 | IDENSTEM | Identification and characterization of enteric nervous system stem cells | 2020 |
| 1115 | RoBE | Study of the role of BANK1 in antibody production and antibody-independent functions of B cells in SLE | 2019 |
| 1116 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
| 1117 | COMPLIMB | A computational tool to elucidate the mechanobiological regulation of limb development | 2019 |
| 1118 | BrEXo-Apt | Non-invasive and accurate diagnosis and treatment of breast cancer. | 2019 |
| 1119 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
| 1120 | PD-MitoQUANT | PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease | 2019 |
| 1121 | CApaCITy | CAncer Stem Cell Imunoreceptors as potential Targets for skin Squamous cell carcinoma | 2019 |
| 1122 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 1123 | UbiGolD | Deciphering ubiquitin-dependent regulation of Golgi homeostasis control in neurodegeneration | 2019 |
| 1124 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 1125 | REBELLION | Light-REsponsive Nanomachines for Targeted Eradication of BactErial Pathogens in LocaLised InfectIONs | 2020 |
| 1126 | SILIA | Solid Immersion Lens Microscopy to Study Cilia Assembly | 2019 |
| 1127 | CLEAN | Well-Confined Mucosal LasEr Ablation with a Negative Pressure Based Endoscopy Capsule | 2019 |
| 1128 | OSTers | Role of OligoSaccharyl Transferase enzymes in developmental signaling and congenital disorders of glycosylation | 2019 |
| 1129 | SyLeNCe | Synapses between Leukaemia and its Neighbouring Cells | 2020 |
| 1130 | SeCRT | Uncover mechanisms of unconventional secretion of tau using functional CRISPR screens - From basic discoveries to neurodegenerative disease therapeutics | 2019 |
| 1131 | MacrophInt | Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance | 2019 |
| 1132 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 1133 | PARNANT | Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s disease | 2019 |
| 1134 | RoboTexTherapy | Textile-based Wearable Mechanotheraphy Device with Liquid/Vapor Phase Change Actuation | 2019 |
| 1135 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 1136 | TRAIN-HEART | TRAIN-HEART | 2019 |
| 1137 | THERAPROBES | Biodegradable fluorescent nanoprobes for early detection of (pre)malignant lesions of the gastrointestinal tract | 2019 |
| 1138 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 1139 | NPsVLCD | Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease | 2019 |
| 1140 | MsgRNA | Modification of single guide (sg) RNA in CRISPR-Cas9 gene editing Tool | 2019 |
| 1141 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 1142 | AR-DDR | Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer | 2019 |
| 1143 | BacDrug | Bacterial membrane vesicles a novel delivery system for the treatment of multi-drug resistant Gram-negative bacterial infections. | 2020 |
| 1144 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 1145 | NSFTA | New Strategies For Therapeutic Antibodies – Synthetic bispecific antibodies & Antibody-Drug Conjugates with controlled drug loading. General methods for unexplored ADCs and personalised therapies. | 2020 |
| 1146 | F4TGLUT | Food for thought: monitoring the effects of drugs and diet on neuronal glutamate release using nanoelectrodes | 2019 |
| 1147 | ProDelivery | High Throughput Synthesis of Polymeric Vesicles for Protein Delivery | 2019 |
| 1148 | EPIOBESITY | Unravelling the hypothalamic epigenetic code behind obesity. | 2020 |
| 1149 | ASTRALIS | ASTRocyte Adrenoceptors: Light on Intracellular Signaling | 2019 |
| 1150 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 1151 | ReproMech | The Molecular Mechanisms of Cell Fate Reprogramming in Vertebrate Eggs | 2019 |
| 1152 | StopIG | Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis | 2019 |
| 1153 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 1154 | PDX-PC | Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer | 2019 |
| 1155 | META2 | METAbolism of bone METAstasis (META2): Metabolic interactions between disseminated breast cancer cells and osteoblast lineage cells drive bone metastases formation | 2019 |
| 1156 | PredAlgoBC | Machine learning prediction for breast cancer therapy | 2019 |
| 1157 | iMIND | iPS-derived MIcroglia and Neuroinflammation in Dementia | 2020 |
| 1158 | Lac-TB | Dissecting the impact of Lactate in Tuberculosis | 2020 |
| 1159 | DADA2GT | Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency | 2019 |
| 1160 | IDEAL | Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia | 2020 |
| 1161 | MetD-AO | Methyl Donating artificial organelles to support liver cells in Non-alcoholic fatty liver disease | 2019 |
| 1162 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 1163 | SingCelCD | Single Cell approaches for the study of oncogenic processes during coeliac disease. | 2019 |
| 1164 | AmnioticID | Understanding the identity of the amniotic fluid stem cells | 2019 |
| 1165 | CAR-OAC | Carotid-artery-on-a-chip device to model thromboembolisms induced by vascular lesions and perform drug screenings | 2020 |
| 1166 | PMLingAML | Using PML nuclear body biology to identify potential AML treatment targets | 2020 |
| 1167 | DynaPIC | Dynamic bonds and polyion complex (PIC) nanoparticles for targeted intracellular peptide delivery | 2020 |
| 1168 | GT-GM1 | Ex vivo gene therapy for GM1-gangliosidosis | 2020 |
| 1169 | Grolaries | Cartilage progenitor cells for growth plate regeneration | 2019 |
| 1170 | GUTPOLAR | Membrane trafficking as a link between cell polarity and intestinal absorptive function: from C. elegans to mammalian miniguts | 2019 |
| 1171 | PHOTOCYLINDER | Photodynamic therapy enabled DNA-fork-binding metallo-cylinders: drugs and release triggers | 2019 |
| 1172 | MINT | Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer | 2019 |
| 1173 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 1174 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 1175 | UreaCa | Deciphering the metabolic roles of the urea-cycle pathway in carcinogenesis for improving diagnosis and therapy | 2019 |
| 1176 | CancerADAPT | Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | 2019 |
| 1177 | MATRIX | Novel mitochondria-targeted therapies for cancer treatment-induced cardiotoxicity | 2019 |
| 1178 | RememberEx | Human Subcortical-Cortical Circuit Dynamics for Remembering the Exceptional | 2019 |
| 1179 | CARDIATEAM | CARdiomyopathy in type 2 DIAbetes mellitus | 2019 |
| 1180 | SYNTISU | Remotely-controlled functional synthetic tissues | 2019 |
| 1181 | TENDO | Tension of ENDOmembranes maintained by TORC1 | 2019 |
| 1182 | OncoViroMRI | Brain Cancer Therapy Monitoring using a Novel Quantitative and Rapid Magnetic Resonance Imaging-based Method | 2019 |
| 1183 | DIVE into AD | Study of tau strains to understand the phenotypic diversity of Alzheimer’s disease: A step toward personalized therapies | 2020 |
| 1184 | NEUROSKIN | Modulating skin innervation to treat cutaneous inflammation | 2019 |
| 1185 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 1186 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 1187 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 1188 | MIMIC | Mapping and modulating integrin mediated interactions | 2020 |
| 1189 | MONET | Merkel cell polyomavirus Oncogenic Network | 2019 |
| 1190 | miR-IBD | Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease | 2019 |
| 1191 | EUREKA | Design of multifunctional phosphorous dendritic systems for drug delivery | 2020 |
| 1192 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 1193 | NeuroFreezing | Biophysical Properties of the Neuronal Cytosol and their Dynamics upon Nutrient Starvation, Aging, and in Neurodegenerative Diseases. | 2019 |
| 1194 | BITFORM | Multiplexed biosensing and tissue-on-a-chip integrated platform for breast cancer biomarkers monitoring | 2019 |
| 1195 | Recruit | Origin and Function of Tumor-Associated Macrophages and Mesenchymal Stromal Cells in GBM Subtypes | 2019 |
| 1196 | LongPlaNet | Long-Range Plasticity of Neuronal Networks in the Adult Brain | 2019 |
| 1197 | RTTOPHAGY | """Investigating autophagy enhancement as a therapeutic approach for the treatment of Rett syndrome.""" | 2019 |
| 1198 | MechanoMVP | Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease | 2019 |
| 1199 | REMAKIN | REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. | 2019 |
| 1200 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 1201 | RIVELIN-CLO | The Ultimate Therapy for the Oral Lichen Planus | 2019 |
| 1202 | RAPID | The first effective remedy for acute pancreatitis disease | 2019 |
| 1203 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 1204 | ISACS | Improving Safety and comfort for kidney transplanted patients by enabling Accurate therapeutic drug monitoring through quantitative Capillary home Sampling | 2019 |
| 1205 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 1206 | CompBioMed2 | A Centre of Excellence in Computational Biomedicine | 2019 |
| 1207 | NEUMACS | Neuron-associated macrophages in the gut as novel target for the treatment of enteric neuropathies | 2019 |
| 1208 | Metabinnate | Metabolic crosstalk in the regulation of inflammation | 2019 |
| 1209 | e-NeuroPharma | Electronic Neuropharmacology | 2019 |
| 1210 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 1211 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
| 1212 | CANSAS | Clustering functional connectivity alterations in Autism Spectrum Disorders | 2020 |
| 1213 | MADMpancreas | Using the precision mouse genetic tool MADM to elucidate the role of EGFR in directing beta cell differentiation and pancreatic morphogenesis | 2019 |
| 1214 | HARMONIC | Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs | 2019 |
| 1215 | MOWA | A novel, modular, smart and patient-centred Ankle-Foot-Orthosis design and production process | 2019 |
| 1216 | GAIA-Health | GAIA-Health: microbiome suite for personalized medicine | 2019 |
| 1217 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 1218 | CeleSte | Commensal microbiota regulation of neuro-immune networks | 2020 |
| 1219 | inSight | Moving a novel gene therapy paradigm to treat blindness to the market | 2019 |
| 1220 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 1221 | ScleroTest | A rapid and cost-effective point-of-care diagnostic kit able to predict treatment response for appropriate Multiple Sclerosis management | 2019 |
| 1222 | INITIATE | INnate-ImmunomeTabolIsm as Antiviral TargEt | 2019 |
| 1223 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 1224 | VERDAD | A blood based biomarker identifying early Alzheimer Disease's pathology | 2019 |
| 1225 | CHAMPION | Cartilage Healing Approach Merging Polymer InnOvation with Nature | 2019 |
| 1226 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 1227 | PATGlycoPrint | Development of a new process analytical technology based on an innovative nanoplasmonic detection array for monitoring glycosylation of monoclonal antibodies | 2019 |
| 1228 | NeoPur | New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling. | 2019 |
| 1229 | UNPACK PD-L1 | Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | 2020 |
| 1230 | NanoPSYCH | Neuropsychiatric disorders are a heterogeneous group of mental pathologies that demand prolonged and treatments that are frequently ineffective. Elucidating the cellular and molecular mechanisms under | 2019 |
| 1231 | ARCAID | Amsterdam Rheumatology Center for AutoImmune Diseases | 2020 |
| 1232 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 1233 | iTrust | In-time TReatment of acUte ischaemic STroke | 2019 |
| 1234 | NextGen-O2k | Next Generation Instrument for In-Depth Analysis of Mitochondrial Fitness | 2019 |
| 1235 | iSTantibody | An innovative & seamless approach for the mass spectrometry analysis of monoclonal antibodies | 2019 |
| 1236 | KOALA FOCUS | KOALA FOCUS: A disruptive e-health approach to treat at home, attention deficits without drugs | 2019 |
| 1237 | MOVEMeNt | Decoding alpha motor neurons diversity and selective vulnerability to disease | 2020 |
| 1238 | BreakingBarriers | Targeting endothelial barriers to combat disease | 2019 |
| 1239 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 1240 | Nano_Brain | Improving drug delivery to the brain and glioblastoma treatment using temperature. | 2019 |
| 1241 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 1242 | ARCH | AGE-RELATED CHANGES IN HEMATOPOIESIS | 2019 |
| 1243 | RODRESET | Development of novel optogenetic approaches for improving vision in macular degeneration | 2019 |
| 1244 | SPELITEC | Sequence sPecific ELImination of shiga-Toxin E. Coli | 2019 |
| 1245 | STRINGHANDBIKE | Innovative push-pull wheelchair accessory to provide mobility, rehabilitation and leisure activities for much more disabled people than today | 2019 |
| 1246 | INVADERS | Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease | 2019 |
| 1247 | EthnoHERBS | Conservation of European Biodiversity through Exploitation of Traditional Herbal Knowledge for the Development of Innovative Products | 2019 |
| 1248 | MABIOS | The first microalgae platform for the production of anticancer biopharmaceuticals | 2019 |
| 1249 | RiboMed | RNA in disease | 2019 |
| 1250 | DrugPhosphoProfiler | Accelerating drug and biomarker discovery through a new proteomic service: DrugPhosphoProfiler | 2019 |
| 1251 | Light4Sight | Light-activated carriers for the controlled delivery of therapeutic peptides in posterior segment eye diseases | 2019 |
| 1252 | TARGET SLEEP | Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease | 2020 |
| 1253 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 1254 | CONNECT-2-CLINIC | Pannexin1 nanobodies for the clinical treatment of liver disease | 2020 |
| 1255 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 1256 | CandidaHunter | A Nanotechnology Based Blood Culture Medium to Detect Invasive Candida in Bloodstream | 2019 |
| 1257 | HYGGii | The therapist in your pocket - AI assisted ecosystem for enabling a patient-centric approach to mental health | 2019 |
| 1258 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 1259 | ConnectToBrain | Connecting to the Networks of the Human Brain | 2019 |
| 1260 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 1261 | TRACER | TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 |
| 1262 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
| 1263 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 1264 | Trials@Home | Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials | 2019 |
| 1265 | ENHPATHY | Molecular basis of human enhanceropathies | 2020 |
| 1266 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 1267 | THERADNET | International NETwork for training and innovations in THErapeutic RADiation | 2019 |
| 1268 | UBIMOTIF | Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities | 2019 |
| 1269 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 1270 | DohART-NET | Periconceptional Programming of Health Training Network | 2019 |
| 1271 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 1272 | TrainCKDis | Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery | 2020 |
| 1273 | SCilS | Studying Ciliary Signaling in Development and Disease | 2020 |
| 1274 | PreMeDosE | Precision Medicine via Diagnostic Enzyme Activity Testing | 2020 |
| 1275 | ONCORNET2.0 | ONCOgenic Receptor Network of Excellence and Training 2.0 | 2020 |
| 1276 | SoMMoR | Soft-bodied Miniature Mobile Robots | 2019 |
| 1277 | mRNA NanoDeli | Application of RNA nanotechnology for delivery of mRNA therapeutics | 2019 |
| 1278 | I-GENE | In-vivo Gene Editing by NanotransducErs | 2019 |
| 1279 | NOVA-MRI | Novel Applications in 19F Magnetic Resonance Imaging | 2020 |
| 1280 | PRIMOGAIA | Prepolarized MRI at Earth Field to seek new contrasts linked to molecular events for very early detection of pathologies | 2019 |
| 1281 | TRS | A paradigm change in the treatment of blinding ocular diseases | 2019 |
| 1282 | MetaboSENS | Metabolic integration by nutrient SENSing | 2019 |
| 1283 | FUELING-TRANSPORT | Deciphering the Role of Huntingtin in Energy Supply for Axonal Transport in Health and Huntington’s Disease | 2020 |
| 1284 | Magicbullet Reloaded | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | 2019 |
| 1285 | TEXAD | TEXAD – Tailoring EXosomes for Autoimmune Diseases | 2019 |
| 1286 | CHANCE | Structure guided inhibition of IDOL to treat atherosclerosis and the metabolic syndrome | 2019 |
| 1287 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
| 1288 | NEUROPA | Non-invasive dynamic neural control by laser-based technology | 2020 |
| 1289 | PEPSA-MATE | Nanopeptides and Nanosaccharides for Advanced and Sustainable Materials | 2020 |
| 1290 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 1291 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 1292 | THERAUTISM | New molecular targets and proof-of-concept therapies for Autism Spectrum Disorders | 2020 |
| 1293 | MOLEC ANTI-ARRHYT | Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design | 2020 |
| 1294 | MABSTER | Monoclonal Antibodies with Binding Sensitive To Environmental Regulation | 2020 |
| 1295 | TroyCAN | Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma | 2020 |
| 1296 | GelGeneCircuit | Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits. | 2020 |
| 1297 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
| 1298 | NanoGut | Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies | 2020 |
| 1299 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 1300 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 1301 | CAPABLE | CAncer PAtients Better Life Experience | 2020 |
| 1302 | CLARIFY | Cancer Long Survivors Artificial Intelligence Follow Up | 2020 |
| 1303 | ONCORELIEF | A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. | 2020 |
| 1304 | FIDA | Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines | 2019 |
| 1305 | Musicon BAND | A complex educational tool based on the power of music, dedicated to preparing children for the challenges of the future by supporting global educational and therapeutic systems. | 2019 |
| 1306 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 1307 | InflaCare | An exosome-based therapeutic approach against chronic inflammation | 2020 |
| 1308 | HominAb | Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases | 2019 |
| 1309 | ADAMO Robot | The future of precise personalised robotic physiotherapy | 2019 |
| 1310 | MiChomAbs | Synthetic Mini-Chromosomes for Antibody Production | 2019 |
| 1311 | FACE | FACE: A real-time facial analysis software to improve the skincare e-commerce. | 2019 |
| 1312 | AXONENDO | Endosomal control of local protein synthesis in axons | 2020 |
| 1313 | IMSquared | Immersive Metaphoric Experiences for Well-Being | 2020 |
| 1314 | RECOGNISED | Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia | 2020 |
| 1315 | REVERT | taRgeted thErapy for adVanced colorEctal canceR paTients | 2020 |
| 1316 | GO-DS21 | Gene overdosage and comorbidities during the early lifetime in Down Syndrome | 2020 |
| 1317 | cmRNAbone | 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients | 2020 |
| 1318 | PROTEOFIT | Adapting protein fate for muscle function and fitness | 2019 |
| 1319 | Synthetic T-rEX | A synthetic biology approach for T cell exhaustion | 2020 |
| 1320 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 1321 | SWORD | Smart Wound monitoring Restorative Dressings | 2020 |
| 1322 | SIROCO | Sparing gene therapy for Inherited ROd COne dystrophies | 2019 |
| 1323 | DBScontrol | Implementation and preclinical testing of a closed-loop control system for deep brain stimulation | 2020 |
| 1324 | AutoCRAT | Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis | 2020 |
| 1325 | BRAINGAIT | BRAIN-ACTUATED SPINAL CORD STIMULATION TO RESTORE GAIT AFTER PARALYSIS | 2019 |
| 1326 | LTS | LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP | 2020 |
| 1327 | CardioProtectMI | A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction | 2019 |
| 1328 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 1329 | PARPinhibit | A systems biology approach to tackle PARP-inhibitors resistance and identify novel therapeutic targets to overcome it | 2020 |
| 1330 | HDM-FUN | Host directed medicine in invasive fungal infection | 2020 |
| 1331 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
| 1332 | FAIR | FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | 2020 |
| 1333 | IP-cure-B | Immune profiling to guide host-directed interventions to cure HBV infections | 2020 |
| 1334 | MISTRAL | Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination | 2020 |
| 1335 | miniNO | Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility | 2020 |
| 1336 | CRUCIAL | MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure | 2020 |
| 1337 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 1338 | NUCDDR | Nucleolar Responses to DNA Damage: rDNA, an emerging hub of genome instability | 2020 |
| 1339 | RibiTool | Ribitol-phosphate: chemical tools to probe the biology of a unique mammalian carbohydrate | 2020 |
| 1340 | ExocyTher | Extracellular vesicle production and engineering by turbulence for fistula therapy in thermoreversible hydrogels | 2020 |
| 1341 | EVEREST | Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy | 2020 |
| 1342 | WINTHER | Fast optoacoustic mesoscopy, using the skin as a window for therapeutic monitoring of local and systemic disease. | 2020 |
| 1343 | discovAIR | Discovering the cellular landscape of the airways and the lung | 2020 |
| 1344 | REMEDIA | Impact of exposome on the course of lung diseases | 2020 |
| 1345 | VANGUARD | New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes | 2020 |
| 1346 | HEDIMED | Human Exposomic Determinants of Immune Mediated Diseases | 2020 |
| 1347 | HUTER | HUMAN UTERUS CELL ATLAS | 2020 |
| 1348 | MInfla-Tilc | Generation of therapeutic antibodies targeting type 2 Innate Lymphoid cells in asthma | 2020 |
| 1349 | READY | Getting ready to treat human patients with nanobody-targeted photodynamic therapy | 2020 |
| 1350 | BlueDot | A long-acting, constant release ocular implant for the sustained delivery of biologics and small molecules for the treatment of retinal diseases. | 2019 |
| 1351 | ImmunoSep | Personalized immunotherapy in sepsis: a precision medicine based approach | 2020 |
| 1352 | DISCOvERIE | Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe | 2020 |
| 1353 | REANIMA | New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms | 2020 |
| 1354 | EIS | An innovative, effective and minimally-invasive retinal cell therapy combined with a new injection system for treatment of retinal degenerative diseases. | 2019 |
| 1355 | ISLET | Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe | 2020 |
| 1356 | OBSERVE | Overcoming cellular barriers to therapeutic RNA delivery using extracellular vesicles | 2020 |
| 1357 | DDREAMM | Dna Damage REsponse: Actionabilities, Maps and Mechanisms | 2020 |
| 1358 | PANACHE | Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases. | 2020 |
| 1359 | EDUC8 | Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity | 2020 |
| 1360 | PDPcardio | Protein phosphatase 1-disrupting peptides: Scope and mechanism of action in the treatment of heart insufficiency | 2020 |
| 1361 | M6AQuantKit | Development and commercialization of kit for quantitative interrogation of a key RNA modification | 2020 |
| 1362 | PureIgY | Towards the use of IgY antibodies as alternative therapeutics | 2020 |
| 1363 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
| 1364 | lncImpact | Long noncoding RNAs: Impact on Gene Regulatory Networks | 2020 |
| 1365 | DissectCMV | Creating a comprehensive functional map of the viral and host factors in HCMV infection | 2020 |
| 1366 | SENATOR | Staff Exchange for Novel applications in 19f magnetic resonance imaging | 2020 |
| 1367 | Trep-AB | Repurposing clinically approved antibacterial drugs for treponematoses therapy | 2020 |
| 1368 | THERA | Therapeutic Drug Monitoring with Smartphone-integrated Surface Enhanced Raman Spectroscopy | 2020 |
| 1369 | PEPTOX | An innovative peptide system for novel drugs targeting microbial Repeats-In-Toxin adhesins | 2020 |
| 1370 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 1371 | Droplet Microarray | Miniaturized System for Screening of Primary Cells based on Droplet Microarray | 2020 |
| 1372 | STRATEGY-CKD | System omics to unravel the gut-kidney axis in Chronic Kidney Disease. | 2020 |
| 1373 | NATURE-ETN | Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification | 2020 |
| 1374 | RNAVirFitness | The dark side of evolution: the deleterious mutational landscape of RNA viruses | 2020 |
| 1375 | ALTER-brain | Metastasis-associated altered molecular patterns in the brain | 2020 |
| 1376 | H I C I | Transcriptional and epigenetic control of tissue regenerative HB-EGF in autoimmune CNS inflammation | 2020 |
| 1377 | ExpoBiome | Deciphering the impact of exposures from the gut microbiome-derived molecular complex in human health and disease | 2020 |
| 1378 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 1379 | RECOBIN-PROTACs | Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy | 2020 |
| 1380 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 1381 | ASTRA | ASsembly and phase Transitions of Ribonucleoprotein Aggregates in neurons: from physiology to pathology. | 2020 |
| 1382 | SynWaiXen | Total Synthesis of Waixenicin A and Xenibellol A | 2020 |
| 1383 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 1384 | SERWOM | Understanding Serotonergic Regulation of Working Memory | 2020 |
| 1385 | UCUPA | Unraveling the Molecular Changes that Drive the Repression of the Unfolded Protein Response with Ageing | 2020 |
| 1386 | Kidney-Treg | Characterisation and impact of kidney-resident Tregs in kidney physiology and pathologies | 2020 |
| 1387 | MY MITOCOMPLEX | Functional relevance of mitochondrial supercomplex assembly in myeloid cells | 2021 |
| 1388 | RE-GENESis | GENome Editing and delivery Strategies for REcoding the mammalian genome | 2020 |
| 1389 | MAESTRO | Magneto-Acoustically Engineered Steerable Robots | 2020 |
| 1390 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 1391 | BRILLIANCE | Bright, coherent and focused light to resolve neural circuits | 2020 |
| 1392 | MiNeMI | Micronnedle-assisted nanovector skin patch for immunomodulation of the inflammatory response upon occurrence of myocardial infarction injury (MiNeMi) | 2020 |
| 1393 | INTEGRATE | Personalised Medicine for Intervertebral Disc Regeneration- Integrating Profiling, Predictive Modelling and Gene Activated Biomaterials | 2020 |
| 1394 | immunoassays | Development of new immunoassays for the diagnosis and prediction of drug-related complement pathology | 2020 |
| 1395 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 1396 | StressRhomboid | Trapping intramembrane protease substrates in living cells: focus on RHBDL4 role in ERAD | 2020 |
| 1397 | xenCAKUT | CRISPR/Cas9 based kidney disease modeling to elucidate novel genetic drivers and therapeutic targets in X. tropicalis | 2020 |
| 1398 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 1399 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |
| 1400 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 1401 | EPmIC | Controlling the susceptibility of biological cells to pulsed electric field treatment by using ion channel modulators | 2021 |
| 1402 | Trojan | Redefining Tsetse symbiont bacteria: A Trojan horse against Trypanosome transmission | 2020 |
| 1403 | TARNEPC | Targeting treatment-induced neuroendocrine prostate cancer | 2021 |
| 1404 | DEFINE | DEciphering mechanisms of presynaptic reFINEment | 2020 |
| 1405 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 1406 | DREAM | Dux4-Regulated Expression and Activity by MATR3 | 2020 |
| 1407 | SUPD | Sizing Up PD: Cavity-enhanced Characterisation of Single Biomarkers in Human Biofluids | 2020 |
| 1408 | FluAttack | Validation of a novel antiviral drug candidate against influenza | 2020 |
| 1409 | GLoopID | Mechanisms underlying regulation and removal of G-quadruplex/R-loop transcription-replication conflicts | 2021 |
| 1410 | PIANISM | Prefrontal Cortex Circuit Dynamics underlying Working Memory and its Serotonin Modulation | 2020 |
| 1411 | AlzheimersInAction | AlzheimersInAction: A multi-disciplinary approach to determine the cellular and molecular mechanisms underlying the inflammatory response to amyloid-β in Alzheimer’s disease. | 2021 |
| 1412 | RegARcis | Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation | 2020 |
| 1413 | RabTarget4Metastasis | Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer | 2020 |
| 1414 | SupraRNA | A Comprehensive Supramolecular Approach for an RNA vaccine for Influenza A (H1N1) | 2020 |
| 1415 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 1416 | SPHERES | Lipid droplet hypertrophy : the link between adipocyte dysfunction and cardiometabolic diseases | 2020 |
| 1417 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |
| 1418 | BioMaGic | Design of biomaterials with enzymatic logic gates | 2021 |
| 1419 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |
| 1420 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 1421 | OPEN P-CAN | Dissecting the role of mitochondrial dynamics in pancreatic carcinogenesis | 2020 |
| 1422 | Pept-AGE | Elucidating the molecular mechanisms of age-related muscle loss to inform Artificial Intelligence-based discovery of novel peptide therapeutics for sarcopenia. | 2020 |
| 1423 | ChondroCONNECT | Development of a connexon-proteoliposome delivery system to ameliorate inflammatory and mechanical stress responses in the regeneration of osteoarthritic cartilage | 2020 |
| 1424 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |
| 1425 | TETCOLON | Dissecting the role of the epigenetic regulator TET2 in colorectal cancer | 2020 |
| 1426 | MRTFSen | MRTF/SRF signalling in regulation of cell senescence and melanoma progression | 2020 |
| 1427 | Ctrl-BBB | Blood-brain barrier: from molecular mechanisms to intervention strategies | 2020 |
| 1428 | ObeSIK3 | Role of SIK3 in energy homeostasis | 2021 |
| 1429 | MITO | The function and biomarker potential of mitochondrial microRNAs in hypertension | 2020 |
| 1430 | RASATaC | Regulating RAS Activity to Target RAS-Driven Cancers | 2020 |